Lichen ruber planus, wide definition including periferal and oral lichen planus

K11_LICHEN_PLANUS_WIDE

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

8767

6. Filter based on genotype QC (FinnGen only)

8767

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF10

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 49313 31731 17388
Only index persons 47551 30823 16728
Unadjusted period prevalence (%)
Whole population 0.76 0.91 0.49
Only index persons 0.96 1.13 0.64
Median age at first event (years)
Whole population 59.19 61.01 56.01
Only index persons 59.11 60.88 55.84

-FinnGen-

Key figures

All Female Male
Number of individuals 8767 5919 2848
Unadjusted period prevalence (%) 1.77 2.02 1.26
Median age at first event (years) 60.78 60.99 60.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
7703
Matched controls
77030
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D07AC13
ATC
mometasone; topical
2.8
323.0
3103
14855
L43.0
ICD-10 Finland
Hypertrophic lichen planus
+∞
323.0
755
*
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
+∞
323.0
1837
*
D07AD01
ATC
clobetasol; topical
5.5
323.0
2835
7402
L43
ICD-10 Finland
Lichen planus
+∞
323.0
1376
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
9.6
323.0
861
997
EKA10
NOMESCO Finland
Biopsy of cheek
28.7
323.0
1110
449
L43.8
ICD-10 Finland
Other lichen planus
+∞
323.0
2658
*
L43.9
ICD-10 Finland
Lichen planus, unspecified
+∞
323.0
2800
*
D07AC01
ATC
betamethasone; topical
4.4
323.0
4405
17963
L43.3
ICD-10 Finland
Subacute (active) lichen planus
+∞
285.1
272
*
SBA00
NOMESCO Finland
Microbiological examinations
9.4
277.0
603
693
E0000UV
ATC
NA
2.4
271.3
3662
21248
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.9
263.7
1960
8102
SAA03
NOMESCO Finland
Extended examination of mouth
2.4
260.3
3507
20189
ECA20
NOMESCO Finland
Biopsy of gingiva
17.4
242.9
393
237
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
8.4
241.2
561
717
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
8.9
219.1
490
585
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.4
211.3
1176
3905
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.2
195.4
2576
14127
K13.29
ICD-10 Finland
Indefinite leukoplakia
13.8
193.3
343
259
D07AB02
ATC
hydrocortisone butyrate; topical
2.2
187.9
2589
14429
K13.78
ICD-10 Finland
Other change in the oral mucosa
8.1
186.5
440
571
L43.1
ICD-10 Finland
Bullous lichen planus
+∞
183.0
175
*
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
174.2
5550
42911
SAA02
NOMESCO Finland
Basic examination of mouth
1.9
157.6
4992
37658
A07AA02
ATC
nystatin; oral
3.4
147.3
796
2543
SXA10
NOMESCO Finland
Epithel biopsy of mouth
10.9
147.1
291
276
A01AC01
ATC
triamcinolone; local oral
6.9
129.7
339
510
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
126.6
2761
17754
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
5.2
125.3
409
815
N77.8*L43.9
ICD-10 Finland
Vulvovaginal ulceration and inflammation caused by lichen ruber planus
143.4
119.5
127
9
E000001
ATC
NA
2.1
118.8
1736
9560
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.9
114.0
1978
11621
L43.2
ICD-10 Finland
Lichenoid drug reaction
+∞
111.7
107
*
69700
ICD-8 Finland
Lichen, Planus
+∞
107.5
103
*
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.7
104.4
4233
32337
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.3
102.4
559
1783
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.7
101.3
4014
30348
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
4.1
100.4
414
1045
D05BB02
ATC
acitretin; oral
5.0
100.0
340
707
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.7
99.7
3486
25397
WX110
NOMESCO Finland
Local anesthesy
1.7
97.4
5172
42213
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.7
96.3
2846
19683
H02AB06
ATC
prednisolone; systemic
1.6
92.3
3610
26909
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.6
92.2
4268
33281
J02AC01
ATC
fluconazole; systemic
1.7
91.5
3220
23304
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.2
90.3
504
1630
D07AB08
ATC
desonide; topical
2.3
86.6
910
4271
L28.0
ICD-10 Finland
Lichen simplex chronicus
8.8
86.1
191
223
SDA02
NOMESCO Finland
Parodonthologic therapy
1.7
85.9
2527
17300
K13.20
ICD-10 Finland
Idiopathic leukoplakia
14.1
84.5
147
106
K02.1
ICD-10 Finland
Caries of dentine
1.6
84.4
4101
32046
ULA02
NOMESCO Finland
Kolposcopy
2.4
84.0
775
3409
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
78.1
3567
27222
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.3
78.0
820
3841
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
75.2
3051
22536
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.8
74.9
522
1953
A01AB09
ATC
miconazole; local oral
2.2
74.7
816
3884
R01AD11
ATC
triamcinolone; nasal
2.2
74.6
806
3816
Z01.2
ICD-10 Finland
Dental examination
1.6
74.1
3025
22354
D20
ICPC
Mouth/tongue/lip symptom/complaint
3.1
73.2
440
1496
R06AE07
ATC
cetirizine; oral
1.6
73.1
3253
24524
D09AB01
ATC
zinc bandage without supplements; topical
4.9
73.0
251
528
XQ802
NOMESCO Finland
Epicutan test
3.1
71.0
412
1366
B37.08
ICD-10 Finland
Other candidal stomatitis
9.8
68.4
142
148
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.7
66.8
1846
12232
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.5
65.6
3294
25317
R06AX27
ATC
desloratadine; oral
1.6
63.6
1940
13175
D07BC01
ATC
betamethasone and antiseptics; topical
2.0
63.4
971
5303
B37.03
ICD-10 Finland
Chronic atrophic candida infection in the mouth
17.9
62.7
99
56
R01AD09
ATC
mometasone; nasal
1.5
62.7
3273
25293
S29
ICPC
Skin symptom/complaint other
1.8
62.2
1310
7983
TQW80
NOMESCO Finland
Local dermatologic skincare
3.7
60.6
283
795
J01DB01
ATC
cefalexin; oral
1.6
59.1
6060
53946
KMAK
NOMESCO Finland
NA
1.5
58.9
3680
29412
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.6
58.8
1888
12947
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
5.5
58.3
178
328
D82
ICPC
Teeth/gum disease
1.5
57.2
2415
17678
LEB00
NOMESCO Finland
Biopsy of vagina
4.3
55.5
216
516
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.5
53.8
2939
22683
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.6
53.2
1716
11728
XQ848
NOMESCO Finland
Dermatological photography
3.5
52.9
256
740
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
12.6
52.9
96
77
R03AC02
ATC
salbutamol; inhalant
1.4
51.7
3760
30648
6970A
ICD-9 Finland
Lichen planus[LICHEN RUBER PLANUS]
+∞
51.1
49
*
K13.22
ICD-10 Finland
Erythroplakia of oral epithelium, including tongue
18.5
50.9
79
43
E000002
ATC
NA
1.9
49.5
802
4445
D02AE01
ATC
carbamide; topical
2.2
49.2
544
2585
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.6
49.2
1764
12341
R06AE09
ATC
levocetirizine; oral
1.7
47.0
1044
6414
K03.64
ICD-10 Finland
Dental calculus supragingival
1.5
46.9
1901
13655
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.8
46.5
911
5380
R01AD08
ATC
fluticasone; nasal
1.5
46.3
2006
14618
A02BC05
ATC
esomeprazole; systemic
1.4
46.2
3019
23913
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.5
45.5
1761
12502
-1
NOMESCO Finland
NA
1.5
45.4
2227
16651
S18
ICPC
Laceration/cut
1.4
45.2
3021
24006
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.5
45.0
374
1544
S21
ICPC
Skin texture symptom/complaint
1.8
44.7
917
5490
A01AB04
ATC
amphotericin B; local oral
2.3
44.5
426
1889
M79.6
ICD-10 Finland
Pain in limb
1.4
44.3
2576
19905
E000006
ATC
NA
2.0
44.2
585
2998
K12.10
ICD-10 Finland
Stomatitis NOS
8.5
43.7
97
115
WZA90
NOMESCO Finland
Other doctors statement
1.5
43.7
1616
11340
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
2.2
42.8
482
2305
N76.3
ICD-10 Finland
Subacute and chronic vulvitis
6.6
42.2
111
170
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.8
41.6
853
5100
N77.8
ICD-10 Finland
Vulvovaginal ulceration and inflammation in other diseases classified elsewhere
40.3
41.5
52
13
J02AC02
ATC
itraconazole; systemic
1.6
41.2
1338
9085
A02BC02
ATC
pantoprazole; systemic
1.4
41.1
4761
41415
EBA00
NOMESCO Finland
Extraction of tooth
1.4
41.1
2196
16629
WX290
NOMESCO Finland
Other blockade of nerve
1.4
40.7
2838
22587
EJ2S1
NOMESCO Finland
Photography of oral mucosa
14.5
40.6
69
48
J01AA02
ATC
doxycycline; systemic
1.4
40.1
5776
52120
M25.5
ICD-10 Finland
Pain in joint
1.5
40.1
2026
15154
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.9
39.6
612
3324
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.8
39.5
799
4755
D19
ICPC
Teeth/gum symptom/complaint
1.5
39.1
1771
12943
EMAK
NOMESCO Finland
NA
2.5
38.0
307
1246
M01AH05
ATC
etoricoxib; oral
1.4
37.8
4249
36505
N02BE01
ATC
paracetamol; systemic, rectal
1.5
37.4
6412
59287
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
5.2
37.4
119
232
K13.2
ICD-10 Finland
Leukoplakia and other disturbances of oral epithelium, including tongue
13.0
37.2
66
51
D07CC01
ATC
betamethasone and antibiotics; topical
1.7
37.0
908
5714
J01CA04
ATC
amoxicillin; systemic
1.4
36.7
5757
52179
SFA00
NOMESCO Finland
Small filling
1.7
36.7
915
5784
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
36.5
2045
15550
M03BX02
ATC
tizanidine; oral
1.4
36.4
4451
38651
D07XC01
ATC
betamethasone, combinations; topical
1.7
36.4
838
5175
TEA00
NOMESCO Finland
Biopsy of lip
4.7
36.0
125
268
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
10.7
35.9
70
66
K05.30
ICD-10 Finland
Periodontitis complex
1.7
35.8
893
5640
J01DA01
ATC
[U] cefalexin; systemic
1.4
35.6
4443
38636
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
35.4
1788
13310
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.6
35.2
902
5738
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
34.9
1474
10580
L17
ICPC
Foot/toe symptom/complaint
1.4
34.8
1764
13137
A98
ICPC
Health maint/preventive medicine
1.8
34.2
7288
69809
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.4
34.0
1804
13541
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
33.9
3007
24692
VALMI
NOMESCO Finland
NA
1.5
33.6
1605
11799
R01AD12
ATC
fluticasone furoate; nasal
1.4
33.4
1927
14689
UJF32
NOMESCO Finland
Coloscopy
1.4
33.4
1824
13763
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.8
33.2
634
3695
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
7.5
32.6
78
105
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
32.5
1472
10696
A02BC03
ATC
lansoprazole; oral
1.4
32.4
2111
16428
SBB10
NOMESCO Finland
Teeth copy
2.1
32.3
383
1873
D07AC14
ATC
methylprednisolone aceponate; topical
2.2
32.2
357
1694
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.7
32.2
697
4219
K12.18
ICD-10 Finland
Other forms of stomatitis
5.5
32.1
97
179
C05AA08
ATC
fluocortolone; rectal, topical
1.6
31.9
1014
6808
E000007
ATC
NA
2.0
31.8
409
2069
K05.31
ICD-10 Finland
Periodontitis pronounced
1.7
31.8
703
4284
SXC05
NOMESCO Finland
Other oral or dental procedure
2.1
31.4
384
1902
K12.00
ICD-10 Finland
Recurrent oral aphthae
4.0
30.9
127
322
H03AA01
ATC
levothyroxine sodium; systemic
1.4
30.8
1740
13175
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.3
30.6
3607
30772
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
30.5
1650
12390
EHA10
NOMESCO Finland
Biopsy of palate
5.6
30.1
89
160
J01FA10
ATC
azithromycin; systemic
1.3
30.0
3958
34280
M01AC06
ATC
meloxicam; systemic, rectal
1.3
29.9
2673
21842
SPAT1153
SPAT
Removal of sutures
1.4
29.8
2255
17944
R01AD01
ATC
beclometasone; nasal
1.5
29.4
1070
7404
D07AA02
ATC
hydrocortisone; topical
1.6
29.4
857
5623
N02AX02
ATC
tramadol; systemic, rectal
1.3
29.4
2930
24326
SPAT1263
SPAT
Sampling
1.3
29.2
2874
23804
G01AA10
ATC
clindamycin; vaginal
1.5
29.2
1046
7210
M54.5
ICD-10 Finland
Low back pain
1.4
29.1
2189
17387
L03
ICPC
Low back symptom/complaint
1.4
29.0
1615
12175
N89.5
ICD-10 Finland
Stricture and atresia of vagina
13.6
28.9
50
37
P01AB01
ATC
metronidazole; oral, rectal
1.3
28.8
2785
22993
R05
ICPC
Cough
1.4
28.7
1489
11078
SPAT1310
SPAT
Counselling related to known health issue
1.4
28.6
2174
17286
N03AX16
ATC
pregabalin; oral
1.4
28.5
1643
12460
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
28.4
2626
21522
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
28.3
6529
61274
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.7
28.0
601
3626
SPAT1312
SPAT
General health counselling
1.4
27.9
2110
16750
XQ800
NOMESCO Finland
Prick test
1.8
27.7
499
2847
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
27.6
1848
14371
SPAT1301
SPAT
No procedures
1.4
27.5
2133
16991
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.8
27.5
515
2979
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
27.4
3160
26702
L08
ICPC
Shoulder symptom/complaint
1.4
27.3
1299
9492
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.6
27.0
741
4786
L66.1
ICD-10 Finland
Lichen planopilaris
20.1
26.9
40
20
N48.1
ICD-10 Finland
Balanoposthitis
3.1
26.4
146
471
R06.0
ICD-10 Finland
Dyspnoea
1.4
26.3
1631
12503
S02
ICPC
Pruritus
2.4
26.3
226
950
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
26.2
1322
9762
L30.0
ICD-10 Finland
Nummular dermatitis
2.3
26.2
246
1083
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
2.4
25.8
227
968
SPAT1260
SPAT
Consultation of another employee
1.4
25.6
1199
8723
K02.0
ICD-10 Finland
Caries limited to enamel
1.6
25.5
784
5203
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
25.5
2323
18921
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
25.5
1535
11701
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
25.3
2018
16102
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
24.9
3401
29282
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.4
24.8
1428
10788
K05.1
ICD-10 Finland
Chronic gingivitis
1.8
24.5
462
2679
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
24.4
1648
12791
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
24.3
2173
17619
M70.6
ICD-10 Finland
Trochanteric bursitis
1.5
24.2
903
6259
R06AX22
ATC
ebastine; oral
1.4
24.2
1133
8235
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
14.9
24.2
40
27
J01FF01
ATC
clindamycin; systemic
1.3
23.7
1791
14143
S08
ICPC
Skin colour change
1.9
23.6
349
1865
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.7
23.4
566
3528
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
23.2
785
5326
L15
ICPC
Knee symptom/complaint
1.4
23.0
1417
10815
N03AX12
ATC
gabapentin; oral
1.4
22.8
1033
7451
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.4
22.6
1022
7370
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
22.4
850
5909
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.4
22.4
1477
11395
R74
ICPC
Upper respiratory infection acute
1.3
22.4
1637
12846
A02BA02
ATC
ranitidine; systemic
1.4
22.3
1325
10046
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
22.3
2558
21418
M01AB05
ATC
diclofenac; systemic, rectal
1.3
22.3
4677
42254
N05BB01
ATC
hydroxyzine; systemic
1.8
22.3
411
2364
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.8
22.1
417
2415
EKC00
NOMESCO Finland
Suture of cheek
15.1
21.9
36
24
L28.1
ICD-10 Finland
Prurigo nodularis
4.2
21.6
82
195
J05AB01
ATC
aciclovir; systemic
1.4
21.6
1376
10545
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.4
21.6
1257
9493
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.4
21.5
1245
9390
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
11.9
21.4
39
33
EJ2S1
SPAT
NA
43.4
21.4
26
6
L44.3
ICD-10 Finland
Lichen ruber moniliformis
43.4
21.4
26
6
D02AX
ATC
Other emollients and protectives
2.2
21.3
223
1033
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
21.2
2446
20459
SPAT1325
SPAT
Vaccination
1.3
21.1
2261
18723
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
3.5
21.1
99
284
TLE00
NOMESCO Finland
Dilatation of vagina
50.1
21.1
25
5
R13
ICD-10 Finland
Dysphagia
1.7
20.9
417
2459
J01MA02
ATC
ciprofloxacin; systemic
1.3
20.9
2523
21222
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
20.8
2907
24897
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
20.8
670
4489
M01AE02
ATC
naproxen; oral, rectal
1.3
20.7
3835
33980
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.0
20.4
283
1477
S99
ICPC
Skin disease other
2.6
20.4
154
607
R52.9
ICD-10 Finland
Pain, unspecified
1.6
20.4
546
3498
R05
ICD-10 Finland
Cough
1.4
20.2
1270
9699
L01
ICPC
Neck symptom/complaint
1.5
20.2
875
6246
D01BA02
ATC
terbinafine; oral; topical
1.3
20.2
1621
12870
N06AX11
ATC
mirtazapine; oral
1.3
20.1
2079
17113
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
20.0
1657
13214
N76.1
ICD-10 Finland
Subacute and chronic vaginitis
3.1
19.9
111
363
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
19.8
1064
7910
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.8
19.7
335
1878
SBA10
NOMESCO Finland
Measurement of excretion of saliva
3.4
19.7
96
285
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
19.6
1862
15140
D05AX52
ATC
calcipotriol, combinations; topical
1.8
19.6
353
2019
J01FA09
ATC
clarithromycin; systemic
1.3
19.6
2085
17219
A02BC01
ATC
omeprazole; systemic
1.3
19.5
1826
14813
K03.66
ICD-10 Finland
Tooth plaque
1.7
19.5
405
2417
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
7.3
19.4
46
63
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
19.3
926
6740
L30.8
ICD-10 Finland
Other specified dermatitis
2.5
18.7
153
629
L20.0
ICD-10 Finland
Besnier prurigo
1.8
18.6
330
1876
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
18.6
1041
7790
M01AX17
ATC
nimesulide; oral
1.3
18.5
1694
13681
L13
ICPC
Hip symptom/complaint
1.4
18.5
1075
8097
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.6
18.4
480
3053
L57.0
ICD-10 Finland
Actinic keratosis
1.5
18.4
601
4041
M79.1
ICD-10 Finland
Myalgia
1.4
18.3
793
5656
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
18.3
642
4386
G47.3
ICD-10 Finland
Sleep apnoea
1.3
18.2
1297
10094
K13
ICD-10 Finland
Other diseases of lip and oral mucosa
7.3
18.1
43
59
M01AX05
ATC
glucosamine; oral
1.3
18.1
1452
11506
D07AC03
ATC
desoximetasone; topical
2.6
18.1
129
494
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
18.0
2788
24050
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.9
18.0
265
1415
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.5
18.0
691
4811
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
17.9
474
3024
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
17.7
1166
8956
N05CF02
ATC
zolpidem; oral
1.4
17.7
1154
8854
F45.8
ICD-10 Finland
Other somatoform disorders
1.7
17.6
372
2233
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
17.6
776
5555
U02
ICPC
Urinary frequency/urgency
1.4
17.5
864
6315
K08.80
ICD-10 Finland
Toothache NOS
1.6
17.5
470
3012
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
17.4
875
6416
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.1
17.4
196
942
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
17.4
2568
21999
K07.60
ICD-10 Finland
Snapping jaw
1.8
17.2
292
1637
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
17.1
1180
9127
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
17.0
1202
9336
G44.2
ICD-10 Finland
Tension-type headache
1.4
17.0
817
5943
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
17.0
652
4535
M02AA07
ATC
piroxicam; topical
1.2
16.9
2502
21428
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.6
16.9
483
3143
K03.00
ICD-10 Finland
Approximal wear
1.8
16.8
305
1749
K04.1
ICD-10 Finland
Necrosis of pulp
1.5
16.8
624
4310
J01FA06
ATC
roxithromycin; oral
1.2
16.8
2706
23395
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
16.7
1935
16085
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.5
16.7
556
3749
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.3
16.7
157
694
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.5
16.7
615
4242
K05.18
ICD-10 Finland
Chronic gingivitis
1.8
16.6
306
1761
L29.2
ICD-10 Finland
Pruritus vulvae
2.9
16.5
102
358
WKPAL
NOMESCO Finland
NA
2.4
16.5
142
603
R05FB02
ATC
cough suppressants and expectorants
1.2
16.3
2543
21889
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
3.7
16.3
70
189
N06AA09
ATC
amitriptyline; systemic
1.5
16.2
680
4818
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.5
16.2
518
3465
SXC03
NOMESCO Finland
Other oral or dental procedure
3.1
16.2
90
296
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.2
16.2
159
719
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.4
16.0
728
5236
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
16.0
680
4829
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
5.2
16.0
49
95
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.6
15.9
407
2579
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.4
15.9
742
5369
K30
ICD-10 Finland
Functional dyspepsia
1.5
15.8
661
4679
R42
ICD-10 Finland
Dizziness and giddiness
1.3
15.8
1368
10929
L30.3
ICD-10 Finland
Infective dermatitis
2.0
15.8
204
1038
L93.0
ICD-10 Finland
Discoid lupus erythematosus
4.5
15.7
55
123
L29.9
ICD-10 Finland
Pruritus, unspecified
2.3
15.6
150
672
R51.80
ICD-10 Finland
Headache
1.4
15.6
847
6295
B35.3
ICD-10 Finland
Tinea pedis
1.9
15.5
231
1239
D06BX01
ATC
metronidazole; topical
1.4
15.5
672
4789
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
15.4
655
4656
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.4
15.3
720
5209
A02BC04
ATC
rabeprazole; oral
1.5
15.3
537
3665
M01AH01
ATC
celecoxib; oral (coxibs)
1.3
15.2
1219
9630
J01FA15
ATC
telithromycin; oral
1.4
15.1
634
4491
N06AX21
ATC
duloxetine; oral
1.4
15.1
665
4757
P01BA02
ATC
hydroxychloroquine; oral
1.5
15.1
550
3787
SGA01
NOMESCO Finland
Tooth opening as first aid
1.4
15.1
890
6709
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
2.6
15.0
110
429
A07EA02
ATC
hydrocortisone; rectal
2.2
15.0
151
690
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.7
15.0
344
2116
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
14.9
2692
23469
K14.61
ICD-10 Finland
Glossodynia
3.5
14.9
70
204
EAA10
NOMESCO Finland
Excision of lesion of lip
2.9
14.8
91
319
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.5
14.8
586
4105
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.5
14.8
498
3369
EKB00
NOMESCO Finland
Excision of lesion of cheek
4.5
14.7
51
113
KGB00
NOMESCO Finland
Biopsy of penis
16.5
14.7
23
14
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.6
14.7
380
2411
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
14.7
1549
12698
EDB00
NOMESCO Finland
Partial excision of mandible
8.6
14.7
31
36
D07AB01
ATC
clobetasone; topical
1.9
14.6
204
1071
L30
ICD-10 Finland
Other dermatitis
2.3
14.6
132
574
R09
ICPC
Sinus symptom/complaint
1.5
14.5
451
2992
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
2.9
14.5
89
310
G04BD12
ATC
mirabegron; oral
1.4
14.5
642
4597
K13.7
ICD-10 Finland
Other and unspecified lesions of oral mucosa
5.8
14.4
40
69
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
1.5
14.4
458
3060
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.7
14.4
275
1604
EBB10
NOMESCO Finland
Insertion of dental implant
2.6
14.3
101
386
N06AX16
ATC
venlafaxine; oral
1.4
14.2
806
6027
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.7
14.2
317
1937
XQ845
NOMESCO Finland
Dermatoscopy
2.8
14.2
92
333
R03BA05
ATC
fluticasone; inhalant
1.3
14.2
1091
8561
H02AB04
ATC
methylprednisolone; systemic
1.3
14.2
927
7100
K13.21
ICD-10 Finland
Leukoplakia caused by tobacco
6.5
14.1
36
56
A03
ICPC
Fever
1.4
14.0
821
6174
PAD
NOMESCO Finland
NA
10.9
14.0
26
24
B37.0
ICD-10 Finland
Candidal stomatitis
2.9
14.0
82
281
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.4
13.9
816
6135
B37.01
ICD-10 Finland
Acute athrophy candidal stomatitis
6.3
13.9
36
57
J01AA04
ATC
lymecycline; systemic
1.4
13.8
718
5294
S87
ICPC
Dermatitis/atopic eczema
2.3
13.7
127
561
S06
ICPC
Rash localized
1.6
13.6
339
2133
J45.9
ICD-10 Finland
Asthma, unspecified
1.3
13.6
1085
8554
N76.6
ICD-10 Finland
Ulceration of vulva
3.5
13.6
63
182
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
1.6
13.6
395
2585
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
13.6
1062
8348
EJB40
NOMESCO Finland
Hemiglossectomy
10.9
13.5
25
23
K03.80
ICD-10 Finland
Irradiated enamel
1.7
13.5
270
1597
R06AX13
ATC
loratadine; oral
1.3
13.4
899
6914
K11.70
ICD-10 Finland
Hypoptyalism
3.5
13.3
60
170
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.4
13.3
625
4527
K13.1
ICD-10 Finland
Cheek and lip biting
4.1
13.2
50
122
M54.6
ICD-10 Finland
Pain in thoracic spine
1.6
13.2
390
2561
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
13.1
953
7407
A01AB10
ATC
natamycin; local oral
1.9
13.0
178
929
F29
ICPC
Eye symptom/complaint other
1.5
13.0
484
3347
K05.12
ICD-10 Finland
Gingivitis (chronic) simple marginal
10.9
13.0
24
22
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
13.0
1440
11852
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
10.0
12.9
25
25
R03BA01
ATC
beclometasone; inhalant
1.3
12.9
870
6689
H02AB07
ATC
prednisone; oral
1.3
12.9
885
6821
L02
ICPC
Back symptom/complaint
1.5
12.8
516
3622
A07EA06
ATC
budesonide; oral, local oral
1.8
12.8
203
1117
D11
ICPC
Diarrhoea
1.4
12.8
589
4246
L14
ICPC
Leg/thigh symptom/complaint
1.5
12.8
438
2973
R60.0
ICD-10 Finland
Localized oedema
1.4
12.7
650
4773
H60.8
ICD-10 Finland
Other otitis externa
2.0
12.7
161
817
N01
ICPC
Headache
1.5
12.6
495
3456
R21
ICPC
Throat symptom/complaint
1.3
12.6
1021
8066
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.4
12.5
104
436
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
3.8
12.5
52
138
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.3
12.5
901
6995
M48.0
ICD-10 Finland
Spinal stenosis
1.4
12.5
748
5647
LFA00
NOMESCO Finland
Incision of vulva or perineum
6.6
12.4
31
47
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
1.9
12.4
193
1054
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
1.4
12.4
590
4280
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.4
12.3
573
4139
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
3.7
12.3
52
140
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
1.8
12.3
208
1171
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.0
12.3
149
744
R96
ICPC
Asthma
1.4
12.3
542
3875
N76.0
ICD-10 Finland
Acute vaginitis
1.7
12.2
245
1453
K14.60
ICD-10 Finland
Glossopyrosis
3.8
12.2
51
136
K14.1
ICD-10 Finland
Geographic tongue
3.7
12.2
52
141
R03BA02
ATC
budesonide; inhalant
1.3
12.2
1046
8324
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.4
12.2
624
4585
SPAT1097
SPAT
Recording of ECG
1.3
12.1
925
7239
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
2.1
12.1
131
622
Z01.9
ICD-10 Finland
Special examination, unspecified
1.6
12.1
343
2228
R03DC03
ATC
montelukast; oral
1.3
12.1
961
7567
N90.4
ICD-10 Finland
Leukoplakia of vulva
4.3
12.0
43
100
UJF30
NOMESCO Finland
Ileoscopy through colon
1.4
12.0
568
4114
104
Kela drug reimbursment
Thyroid insufficiency
1.4
11.9
490
3457
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
4.1
11.9
45
110
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.2
11.9
1668
14087
KGH10
NOMESCO Finland
Operation for phimosis
2.2
11.9
115
522
D83
ICPC
Mouth/tongue/lip disease
3.9
11.9
48
125
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.6
11.8
323
2082
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.5
11.8
419
2867
R07.0
ICD-10 Finland
Pain in throat
1.6
11.8
326
2107
J01EA01
ATC
trimethoprim; systemic
1.2
11.8
1614
13591
P03
ICPC
Feeling depressed
1.5
11.8
433
2988
K05.08
ICD-10 Finland
Another acute gingivitis
2.1
11.8
133
644
S01
ICPC
Pain/tenderness of skin
1.7
11.7
250
1508
G04CA02
ATC
tamsulosin; oral
1.3
11.7
973
7708
M01AX01
ATC
nabumetone; oral
1.6
11.7
283
1770
L12
ICPC
Hand/finger symptom/complaint
1.3
11.7
836
6482
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
1.4
11.7
589
4318
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.4
11.6
538
3885
8070/3-C06.0
ICD-O-3
Squamous cell carcinoma, NOS, of cheeck mucosa
18.9
11.6
17
9
D07XB05
ATC
dexamethasone, combinations; topical
1.9
11.5
158
827
L50.3
ICD-10 Finland
Dermatographic urticaria
2.3
11.5
101
437
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.4
11.5
654
4890
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
13.6
11.4
19
14
H13
ICPC
Plugged feeling ear
1.3
11.4
1047
8406
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.4
11.4
699
5293
L28
ICPC
Limited function/disability (L)
1.3
11.4
935
7392
UKC02
NOMESCO Finland
Cystoscopy
1.3
11.4
867
6785
J05AB11
ATC
valaciclovir; oral
1.3
11.4
803
6214
M79.7
ICD-10 Finland
Fibromyalgia
1.8
11.4
201
1149
SDA05
NOMESCO Finland
Very demanding and lengthy parodonthologic therapy
1.6
11.3
291
1849
H29
ICPC
Ear symptom/complaint other
1.4
11.3
592
4368
B03BA03
ATC
hydroxocobalamin; parenteral
1.6
11.3
303
1945
R02
ICPC
Shortness of breath/dyspnoea
1.4
11.3
699
5299
L73.8
ICD-10 Finland
Other specified follicular disorders
3.3
11.3
55
167
K13.03
ICD-10 Finland
Keilit UNS
5.2
11.3
34
66
A04
ICPC
Weakness/tiredness general
1.3
11.3
709
5391
D01AC02
ATC
miconazole; topical
1.4
11.2
450
3161
B37.02
ICD-10 Finland
Chronic hyperplastic candidal stomatitis
8.9
11.2
23
26
R35
ICD-10 Finland
Polyuria
1.5
11.2
330
2168
B35.1
ICD-10 Finland
Tinea unguium
1.6
11.2
311
2013
M54.2
ICD-10 Finland
Cervicalgia
1.5
11.2
404
2778
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.4
11.2
531
3850
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
11.2
930
7365
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.4
11.2
466
3299
D01AE15
ATC
terbinafine; topical
1.5
11.1
388
2649
E000003
ATC
NA
1.6
11.1
262
1630
E03
ICD-10 Finland
Other hypothyroidism
1.5
11.1
364
2451
K29.4
ICD-10 Finland
Chronic atrophic gastritis
2.0
11.0
134
670
K60.1
ICD-10 Finland
Chronic anal fissure
2.0
11.0
134
672
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.4
11.0
470
3343
SGA05
NOMESCO Finland
Very demanding and lengthy opening and dilatation of root canal of tooth
1.6
10.9
308
2000
J01AA07
ATC
tetracycline; systemic
1.3
10.9
837
6555
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
10.8
1039
8382
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
10.8
2160
18877
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.4
10.8
478
3421
ECA30
NOMESCO Finland
Excision of lesion of gingiva
2.6
10.8
76
292
SPAT1058
SPAT
PEF monitoring instruction
1.4
10.8
503
3635
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.0
10.7
141
728
Z71.8
ICD-10 Finland
Other specified counselling
1.2
10.7
1364
11385
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
2.0
10.7
127
629
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.5
10.7
367
2499
N06AB04
ATC
citalopram; systemic
1.2
10.7
1318
10965
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
1.5
10.6
395
2732
F51.0
ICD-10 Finland
Nonorganic insomnia
1.3
10.5
697
5341
N05BA04
ATC
oxazepam; oral
1.2
10.5
1499
12667
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.6
10.5
238
1467
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
1.4
10.4
470
3377
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.2
10.4
2244
19733
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
10.4
1133
9282
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
10.4
290
1880
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.6
10.4
265
1682
L71.0
ICD-10 Finland
Perioral dermatitis
2.5
10.4
77
305
B81
ICPC
Anaemia vit B12/folate deficiency
1.7
10.3
208
1239
J01CA08
ATC
pivmecillinam; oral
1.2
10.3
2686
24017
A11
ICPC
Chest pain NOS
1.4
10.3
436
3095
R03AC03
ATC
terbutaline; inhalant
1.3
10.3
825
6500
L12.0
ICD-10 Finland
Bullous pemphigoid
3.6
10.2
44
122
B86
ICD-10 Finland
Scabies
2.4
10.2
83
347
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
10.2
4502
42024
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.5
10.2
340
2301
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.2
10.2
1284
10702
T84.60
ICD-10 Finland
Gingivitis associated with dental implants
3.3
10.1
49
149
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
1.4
10.1
418
2955
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.3
10.1
828
6546
K14.9
ICD-10 Finland
Disease of tongue, unspecified
4.4
10.1
35
80
R06.5
ICD-10 Finland
Mouth breathing
1.4
10.1
462
3332
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
10.0
1597
13636
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
2.2
10.0
97
443
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
1.7
10.0
203
1211
J01MA06
ATC
norfloxacin; oral
1.3
10.0
828
6549
E000004
ATC
NA
2.0
10.0
122
611
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.3
10.0
681
5241
SPAT1043
SPAT
Audiometry
1.3
9.9
605
4575
E03.89
ICD-10 Finland
Other specified hypothyroidism
1.7
9.9
210
1269
H01
ICPC
Ear pain/earache
1.4
9.9
574
4309
N17
ICPC
Vertigo/dizziness
1.3
9.9
640
4889
L44.1
ICD-10 Finland
Lichen nitidus
20.0
9.8
14
7
R03BA08
ATC
ciclesonide; inhalant
1.4
9.7
478
3489
M13.9
ICD-10 Finland
Arthritis, unspecified
1.4
9.6
397
2806
M01AH02
ATC
rofecoxib; oral
1.3
9.6
830
6602
L29.0
ICD-10 Finland
Pruritus ani
2.8
9.6
58
206
A46
ICD-10 Finland
Erysipelas
1.3
9.6
766
6029
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
3.5
9.6
42
119
J45
ICD-10 Finland
Asthma
1.4
9.6
560
4209
K60.2
ICD-10 Finland
Anal fissure, unspecified
2.2
9.5
95
440
A03FA02
ATC
cisapride; oral, rectal
1.4
9.5
458
3330
A02BA04
ATC
nizatidine; systemic
1.4
9.5
451
3274
M54
ICD-10 Finland
Dorsalgia
1.3
9.5
614
4689
A01
ICPC
Pain general/multiple sites
1.4
9.5
444
3215
K02.2
ICD-10 Finland
Caries of cementum
1.6
9.4
243
1552
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.5
9.4
332
2275
XKD00
NOMESCO Finland
Uroflowmetry
1.3
9.4
720
5640
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.5
9.4
286
1899
L20.8
ICD-10 Finland
Other atopic dermatitis
2.7
9.3
63
237
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
9.3
807
6423
Z70.8
ICD-10 Finland
Other sex counselling
5.5
9.3
26
47
R03AK07
ATC
formoterol and budesonide; inhalant
1.2
9.2
1111
9199
ZXD20
NOMESCO Finland
Day surgery
1.3
9.2
761
6013
C07AA05
ATC
propranolol; systemic
1.2
9.2
1133
9401
S88
ICPC
Dermatitis contact/allergic
2.0
9.2
116
590
SPAT1336
SPAT
Request for examination
1.6
9.2
207
1275
EJW99
NOMESCO Finland
Other operation on tongue or floor of mouth
13.7
9.2
15
11
S22
ICPC
Nail symptom/complaint
1.5
9.2
309
2099
D01
ICPC
Abdominal pain/cramps general
1.3
9.1
573
4352
K13.09
ICD-10 Finland
Disease of the lips UNS
6.2
9.1
23
37
N05CF01
ATC
zopiclone; oral
1.2
9.0
2036
17934
D01AE16
ATC
amorolfine; topical
1.3
9.0
708
5560
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.3
8.9
613
4720
WX110
SPAT
NA
1.6
8.9
239
1537
N95.0
ICD-10 Finland
Postmenopausal bleeding
1.3
8.9
566
4313
P06
ICPC
Sleep disturbance
1.3
8.9
527
3974
L71.8
ICD-10 Finland
Other rosacea
2.2
8.9
86
395
N06AB03
ATC
fluoxetine; oral
1.3
8.8
739
5852
S02.51
ICD-10 Finland
Fracture of tooth, open
1.3
8.8
573
4375
J01MA12
ATC
levofloxacin; systemic
1.2
8.8
1055
8728
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.2
8.8
1206
10125
S82
ICPC
Naevus/mole
1.3
8.8
675
5285
B37
ICD-10 Finland
Candidiasis
4.9
8.8
27
55
J33.0
ICD-10 Finland
Polyp of nasal cavity
1.8
8.7
150
854
C10AX09
ATC
ezetimibe; oral
1.3
8.7
639
4975
N06AB10
ATC
escitalopram; oral
1.2
8.7
1096
9126
K95
ICPC
Varicose veins of leg
2.2
8.7
87
406
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.5
8.6
274
1836
K10.3
ICD-10 Finland
Alveolitis of jaws
1.6
8.6
217
1379
L29.8
ICD-10 Finland
Other pruritus
2.4
8.6
67
277
UJH02
NOMESCO Finland
Anoscopy
1.5
8.6
245
1602
H93.1
ICD-10 Finland
Tinnitus
1.4
8.6
363
2578
H92.0
ICD-10 Finland
Otalgia
1.5
8.6
272
1820
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.3
8.6
599
4628
L50.9
ICD-10 Finland
Urticaria, unspecified
1.7
8.5
180
1088
G03CA04
ATC
estriol; systemic, vaginal
1.4
8.5
463
3439
K07
ICPC
Swollen ankles/oedema
1.6
8.5
235
1525
J01FA01
ATC
erythromycin; systemic
1.3
8.5
739
5879
Z00.0
ICD-10 Finland
General medical examination
1.2
8.5
1047
8689
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
1.5
8.4
278
1877
M45
ICD-10 Finland
Ankylosing spondylitis
1.9
8.4
110
568
R52.2
ICD-10 Finland
Other chronic pain
1.7
8.4
184
1123
C10AC01
ATC
colestyramine; oral
1.7
8.4
153
887
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
8.4
752
6005
SPA30
NOMESCO Finland
Grinding of a single crown and bridge pillar or a single post and crown
2.5
8.4
65
266
R49.08
ICD-10 Finland
Other specified dysphonia
1.8
8.3
126
690
K14.69
ICD-10 Finland
Tongue pain UNS
3.3
8.3
40
123
A07EC02
ATC
mesalazine; oral, rectal
1.5
8.3
285
1942
L82
ICD-10 Finland
Seborrhoeic keratosis
1.2
8.3
945
7774
L28.2
ICD-10 Finland
Other prurigo
3.6
8.3
35
97
8070/3-C02.9
ICD-O-3
Squamous cell carcinoma, NOS, of tongue, NOS
8.5
8.3
17
20
DFF00
NOMESCO Finland
Pure tone audiometry
1.3
8.3
506
3829
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.3
8.3
607
4724
SPAT1240
SPAT
Therapeutic discussion
1.3
8.3
515
3913
R01AD05
ATC
budesonide; nasal
1.4
8.3
444
3295
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
8.2
708
5628
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.3
8.2
666
5250
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.5
8.2
296
2040
K12
ICD-10 Finland
Stomatitis and related lesions
4.7
8.2
26
55
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
2.5
8.2
60
238
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
1.5
8.2
266
1793
UDC00
NOMESCO Finland
Ear microscopy
1.4
8.2
389
2829
R07
ICPC
Sneezing/nasal congestion
1.5
8.1
292
2009
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.3
8.1
831
6752
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.3
8.1
510
3880
WX002
NOMESCO Finland
Sedation and analgesia
1.2
8.1
1200
10153
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.3
8.1
489
3697
SCF02
NOMESCO Finland
Preventive oral care by dental hygienist
1.7
8.1
155
913
N81.6
ICD-10 Finland
Rectocele
1.4
8.1
436
3238
S15
ICPC
Foreign body in skin
1.4
8.1
345
2460
N48.5
ICD-10 Finland
Ulcer of penis
8.1
8.1
17
21
A97
ICPC
No disease
1.3
8.1
815
6611
SPA41
NOMESCO Finland
Precision impression for fixed dental prosthesis
2.3
8.0
74
330
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
2.0
8.0
99
504
U07
ICPC
Urine symptom/complaint other
1.4
8.0
329
2328
EEB00
NOMESCO Finland
Partial excision of maxilla
10.0
8.0
15
15
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
1.9
8.0
105
547
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.3
8.0
702
5598
N76.8
ICD-10 Finland
Other specified inflammation of vagina and vulva
2.4
8.0
66
282
K07.23
ICD-10 Finland
Deep bite
2.0
8.0
91
448
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
1.4
7.9
378
2753
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
1.7
7.9
158
945
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
4.5
7.8
26
58
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.4
7.8
401
2954
LEA10
NOMESCO Finland
Colpotomy
10.8
7.8
14
13
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
7.8
1674
14661
R07.3
ICD-10 Finland
Other chest pain
1.3
7.8
522
4013
ZXA05
NOMESCO Finland
Left side
1.2
7.7
1571
13684
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.3
7.7
537
4143
ZXA00
NOMESCO Finland
Right side
1.2
7.7
1680
14721
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.3
7.7
561
4360
D10.39
ICD-10 Finland
Benign tumor in other or unspecified part of oral cavity UNS
3.7
7.7
31
83
A60
ICPC
General and Unspecified, Result test/procedure
1.5
7.7
235
1565
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.4
7.7
299
2091
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.3
7.7
688
5498
N03AX09
ATC
lamotrigine; oral
1.5
7.7
215
1404
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.4
7.7
383
2805
EBB15
NOMESCO Finland
Insertion of dental implant abutment
2.6
7.7
53
204
M01AG02
ATC
tolfenamic acid; oral, rectal
1.2
7.7
909
7512
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
1.6
7.6
199
1277
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
1.3
7.6
548
4252
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.6
7.6
205
1326
N06AX26
ATC
vortioxetine; oral
1.5
7.6
252
1709
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.4
7.6
312
2205
N39.3
ICD-10 Finland
Stress incontinence
1.3
7.6
456
3443
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
1.8
7.6
125
704
L44.2
ICD-10 Finland
Lichen striatus
18.4
7.6
11
6
H01.0
ICD-10 Finland
Blepharitis
1.5
7.6
282
1957
ZX198
NOMESCO Finland
Other local administration
2.4
7.6
60
251
R12
ICD-10 Finland
Heartburn
1.4
7.6
391
2882
HMAK
NOMESCO Finland
NA
1.3
7.6
655
5212
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.6
7.5
196
1255
I10
ICD-10 Finland
Essential (primary) hypertension
1.1
7.5
3816
35601
L12.8
ICD-10 Finland
Other pemphigoid
8.8
7.5
15
17
Y04
ICPC
Penis symptom/complaint other
3.6
7.5
32
90
D02
ICPC
Abdominal pain epigastric
1.4
7.5
315
2237
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.2
7.5
1109
9378
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
2.0
7.5
85
417
L04
ICPC
Chest symptom/complaint
1.4
7.5
309
2189
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.3
7.4
602
4746
I84.5
ICD-10 Finland
External hemorrhoids without complication
1.6
7.4
177
1109
L40.8
ICD-10 Finland
Other psoriasis
2.5
7.4
53
211
L28
ICD-10 Finland
Lichen simplex chronicus and prurigo
2.5
7.4
53
211
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.4
7.4
284
1985
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.3
7.4
453
3435
A07EC01
ATC
sulfasalazine; oral, rectal
1.3
7.4
453
3435
-
ICD-10 Finland
NA
1.7
7.4
134
777
K90.0
ICD-10 Finland
Coeliac disease
1.7
7.4
155
941
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.3
7.4
673
5391
X15
ICPC
Vaginal symptom/complaint other
1.7
7.4
148
887
S76
ICPC
Skin infection other
1.5
7.3
266
1836
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.2
7.3
971
8115
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
1.3
7.3
636
5063
L42
ICD-10 Finland
Pityriasis rosea
3.5
7.3
32
92
G03CC04
ATC
estrone; systemic
1.6
7.3
200
1297
L16
ICPC
Ankle symptom/complaint
1.3
7.3
550
4292
Y29
ICPC
Genital symptom/complaint male other
3.9
7.3
28
72
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.4
7.3
351
2557
SPC01
NOMESCO Finland
Fixed dental crown
2.2
7.3
72
334
K80
ICPC
Cardiac arrhythmia NOS
1.4
7.3
411
3074
R83
ICPC
Respiratory infection other
1.2
7.3
1178
10046
D01AA02
ATC
natamycin; topical
1.8
7.3
113
625
8070/3-C03.1
ICD-O-3
Squamous cell carcinoma, NOS, of lower gum
10.8
7.3
13
12
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.3
7.3
692
5571
EJB99
NOMESCO Finland
Other excision on tongue and floor of mouth
9.3
7.3
14
15
D03
ICPC
Heartburn
1.6
7.2
167
1038
A99
ICPC
Disease/condition unspecnature/site
1.3
7.2
428
3225
-60
ICPC
Result test/procedure
1.4
7.2
311
2225
K04.08
ICD-10 Finland
Other specified pulpit
1.4
7.2
301
2140
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.3
7.2
438
3320
M02AA10
ATC
ketoprofen; topical
1.2
7.2
957
8004
D06BB03
ATC
aciclovir; topical
1.4
7.2
278
1945
B35.6
ICD-10 Finland
Tinea inguinalis [Tinea cruris]
2.0
7.1
81
401
L57.8
ICD-10 Finland
Other skin changes due to chronic exposure to nonionizing radiation
3.7
7.1
29
79
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.3
7.1
596
4725
N51.8*A60.0
ICD-10 Finland
Herpes simplex infection of the genitals in men
7.9
7.1
15
19
Z01.7
ICD-10 Finland
Laboratory examination
1.3
7.1
594
4707
SPAT1081
SPAT
Cardiorespiratory global assessment
1.4
7.1
316
2276
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
2.1
7.1
78
382
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
1.7
7.0
138
821
P20
ICPC
Memory disturbance
1.3
7.0
630
5037
C10AA04
ATC
fluvastatin; oral
1.3
7.0
477
3675
SPAT1283
SPAT
Restricted health certificate
1.2
7.0
746
6094
EBA10
NOMESCO Finland
Surgical removal of tooth
1.3
7.0
527
4120
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
1.5
7.0
261
1817
SFC00
NOMESCO Finland
Pillar of fillings material
1.6
6.9
161
1006
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
2.1
6.9
69
323
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
2.4
6.9
56
239
K11.2
ICD-10 Finland
Sialoadenitis
1.6
6.9
170
1078
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
1.9
6.9
90
472
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.4
6.9
367
2723
SPAT1211
SPAT
Application of soft bandage
1.3
6.9
490
3799
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.5
6.8
235
1608
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
1.6
6.8
174
1110
M01AH03
ATC
valdecoxib; oral
1.4
6.8
370
2752
L27.1
ICD-10 Finland
Localized skin eruption due to drugs and medicaments
3.3
6.8
31
93
H02.3
ICD-10 Finland
Blepharochalasis
1.4
6.8
367
2732
R60.9
ICD-10 Finland
Oedema, unspecified
1.5
6.8
250
1737
R06.2
ICD-10 Finland
Wheezing
1.5
6.8
216
1453
D06
ICPC
Abdominal pain localized other
1.3
6.7
432
3300
QBA
NOMESCO Finland
Incision or local destruction of lesion of skin of trunk
16.7
6.7
10
6
U05
ICPC
Urination problems other
1.5
6.7
229
1563
K59.0
ICD-10 Finland
Constipation
1.4
6.7
293
2102
A08
ICPC
Swelling
1.5
6.7
223
1515
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.3
6.7
547
4321
M67.4
ICD-10 Finland
Ganglion
1.4
6.7
340
2502
ZZQ20
NOMESCO Finland
Free microvascular graft of skin, muscle and bone
22.5
6.7
9
*
H00.1
ICD-10 Finland
Chalazion
1.6
6.7
177
1143
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
1.5
6.7
209
1401
M19.8
ICD-10 Finland
Other specified arthrosis
1.5
6.7
191
1257
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
2.1
6.6
67
314
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.6
6.6
175
1127
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.3
6.6
626
5039
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.5
6.6
204
1364
ECB00
NOMESCO Finland
Suture of gingiva
1.6
6.6
175
1131
M77.1
ICD-10 Finland
Lateral epicondylitis
1.4
6.6
359
2674
LCA06
NOMESCO Finland
Biopsy of endometrium
1.2
6.6
696
5675
X16
ICPC
Vulval symptom/complaint
2.2
6.6
62
284
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
2.1
6.6
65
305
L12.1
ICD-10 Finland
Cicatricial pemphigoid
12.2
6.6
11
9
J30.3
ICD-10 Finland
Other allergic rhinitis
1.6
6.6
163
1035
1412
FHL
Laparoscopy and sterilization
1.3
6.6
472
3665
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.2
6.6
693
5650
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
1.8
6.5
112
641
G01AF01
ATC
metronidazole; vaginal
1.3
6.5
624
5029
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.4
6.5
338
2496
C02.10
ICD-10 Finland
Malignant neoplasm of tip of tongue
10.0
6.5
12
12
ZXC10
NOMESCO Finland
Use of laser
1.7
6.5
121
711
T78.3
ICD-10 Finland
Angioneurotic oedema
2.0
6.5
74
368
K13.00
ICD-10 Finland
Cheilitis NOS
3.1
6.5
32
102
XF402
NOMESCO Finland
ECG with work load test
1.3
6.5
633
5112
L20
ICD-10 Finland
Atopic dermatitis
1.8
6.5
99
548
L11
ICPC
Wrist symptom/complaint
1.3
6.5
407
3099
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.3
6.5
472
3671
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.4
6.5
365
2732
U01
ICPC
Dysuria/painful urination
1.3
6.5
408
3107
A63.0
ICD-10 Finland
Anogenital (venereal) warts
1.6
6.5
143
884
K05.0
ICD-10 Finland
Acute gingivitis
1.7
6.5
115
667
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
2.1
6.5
69
335
M01AB08
ATC
etodolac; oral
1.3
6.4
425
3266
M16.1
ICD-10 Finland
Other primary coxarthrosis
1.3
6.4
655
5322
E0001A1
ATC
NA
1.9
6.4
90
485
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
1.7
6.4
130
784
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
2.2
6.4
60
273
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
1.7
6.4
116
678
R03AC13
ATC
formoterol; inhalant
1.4
6.4
262
1861
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.5
6.4
183
1206
R20.2
ICD-10 Finland
Paraesthesia of skin
1.4
6.4
334
2473
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
2.1
6.4
66
317
SPA02
NOMESCO Finland
Preparation for dental prosthetics
1.7
6.4
121
716
D11AH01
ATC
tacrolimus; topical
2.6
6.3
42
161
XKC03
NOMESCO Finland
Water cystometry
1.5
6.3
181
1190
SPAT1281
SPAT
Other administrative function
1.3
6.3
416
3192
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.3
6.3
556
4436
P01
ICPC
Feeling anxious/nervous/tense
1.3
6.3
418
3208
Z02.4
ICD-10 Finland
Examination for driving licence
1.2
6.3
1251
10863
J37.0
ICD-10 Finland
Chronic laryngitis
1.6
6.3
165
1064
B48.8
ICD-10 Finland
Other specified mycoses
5.5
6.3
17
31
R04.0
ICD-10 Finland
Epistaxis
1.4
6.3
354
2651
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
2.5
6.3
45
180
107
Kela drug reimbursment
Pernicious anaemia
1.8
6.3
100
559
R44
ICPC
Respiratory, Preventive immunization/medic
1.9
6.3
85
453
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
2.9
6.3
36
125
J34.2
ICD-10 Finland
Deviated nasal septum
1.4
6.3
252
1783
G03CB01
ATC
dienestrol; oral, vaginal
1.6
6.3
163
1049
R30.0
ICD-10 Finland
Dysuria
1.5
6.2
180
1185
N30
ICD-10 Finland
Cystitis
1.3
6.2
389
2962
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.3
6.2
479
3756
I49.1
ICD-10 Finland
Atrial premature depolarization
1.5
6.2
183
1212
L29
ICD-10 Finland
Pruritus
2.1
6.2
65
313
M54.8
ICD-10 Finland
Other dorsalgia
1.5
6.2
210
1435
G03FB05
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.2
6.2
769
6381
EB1MA
NOMESCO Finland
Cephalometry with X-ray
1.9
6.2
82
430
A06AD11
ATC
lactulose; oral
1.2
6.2
736
6081
K59.9
ICD-10 Finland
Functional intestinal disorder, unspecified
2.0
6.2
71
352
H02
ICPC
Hearing complaint
1.2
6.2
669
5468
XQ899
NOMESCO Finland
Other assessment of skin
3.0
6.2
32
106
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
1.7
6.2
128
775
N77.1*B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
2.1
6.2
67
328
M77.4
ICD-10 Finland
Metatarsalgia
1.4
6.2
296
2159
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
1.8
6.1
103
587
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
2.1
6.1
61
285
R39.1
ICD-10 Finland
Other difficulties with micturition
1.6
6.1
136
840
T78.4
ICD-10 Finland
Allergy, unspecified
1.5
6.1
216
1488
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
2.0
6.1
69
343
K04
ICPC
Palpitations/awareness of heart
1.4
6.1
271
1952
R29
ICPC
Respiratory symptom/complaint other
1.4
6.1
325
2413
S01.50
ICD-10 Finland
Open wound in oral cavity
2.2
6.1
56
254
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
1.7
6.1
110
642
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
2.2
6.1
59
275
H10
ICD-10 Finland
Conjunctivitis
1.4
6.1
298
2184
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
2.4
6.1
45
185
ELB10
NOMESCO Finland
Excision of minor salivary gland
4.0
6.1
22
55
DJD20
NOMESCO Finland
Plastic repair of septum of nose
1.5
6.1
172
1131
D07CB01
ATC
triamcinolone and antibiotics; topical
1.7
6.1
120
719
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.4
6.0
324
2409
E66.01
ICD-10 Finland
Obesity due to excess calories
1.3
6.0
379
2886
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
1.9
6.0
77
402
N76.2
ICD-10 Finland
Acute vulvitis
2.9
6.0
33
114
K59.09
ICD-10 Finland
Constipation, unspecified
1.4
6.0
309
2283
N04BC05
ATC
pramipexole; oral
1.3
6.0
412
3180
G43.9
ICD-10 Finland
Migraine, unspecified
1.4
6.0
236
1661
L21.0
ICD-10 Finland
Seborrhoea capitis
2.2
6.0
55
248
L73.9
ICD-10 Finland
Follicular disorder, unspecified
3.3
6.0
27
81
R53
ICD-10 Finland
Malaise and fatigue
1.2
6.0
1102
9500

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026389) Candida sp identified in Specimen by Organism specific culture
600
1049
6.07
307.65
1.9
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
1175
3359
3.88
307.65
1.3
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
1649
8909
2.05
134.03
1.7
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
4292
31420
1.72
129.07
2.4
2.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
228
560
4.15
83.06
1.5
1.5
u/ml
19.8
20.0
0.03
52
113
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
205
464
4.50
83.03
1.3
1.3
titre
50.9
59.1
0.22
22
34
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
208
483
4.39
81.55
1.3
1.3
titre
443.0
339.5
—
10
39
(3013707) Erythrocyte sedimentation rate by Westergren method
6519
56326
1.61
79.22
4.7
4.2
mm/h
12.3
12.8
2.13
6042
52086
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
6697
58588
1.61
73.61
4.8
4.2
pmol/l
14.8
14.9
0.51
6080
53193
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2293
16109
1.57
69.09
1.3
1.3
u/ml
1.6
1.8
0.28
637
4222
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
7616
69219
1.76
68.22
5.8
5.0
mu/l
2.2
2.1
0.16
6996
63282
(3037522) Nuclear Ab [Titer] in Serum
1546
10330
1.60
56.06
1.5
1.3
titre
544.9
539.4
0.04
347
2240
(3037467) Urinalysis macro (dipstick) panel - Urine
5916
51645
1.45
54.07
5.0
4.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1960
13957
1.52
53.22
1.4
1.5
g/l
2.5
2.5
0.10
1163
8228
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6590
59021
1.47
50.19
7.8
7.7
u/l
76.8
78.5
2.52
6215
55503
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3865
31593
1.40
49.43
2.1
2.0
pmol/l
96.5
97.0
0.23
1904
15790
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
7949
74375
1.74
48.32
15.4
14.6
mg/l
21.0
23.4
9.14
6391
59105
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
7532
69683
1.57
46.00
6.4
5.9
mmol/mol
39.9
39.8
0.04
6967
64234
(3013115) Eosinophils [#/volume] in Blood
4576
38757
1.38
45.82
6.3
6.1
e9/l
0.2
0.2
2.51
4033
33808
(3006315) Basophils [#/volume] in Blood
4448
37517
1.38
45.60
6.1
5.9
e9/l
0.0
0.0
1.37
3878
32200
(3031040) Bacteria [#/volume] in Urine by Automated count
5651
49676
1.39
44.18
5.1
4.6
e6/l
372.7
2045.7
4.85
57
663
(3023103) Potassium [Moles/volume] in Serum or Plasma
8194
77628
1.85
43.88
17.5
16.8
mmol/l
4.0
4.0
0.49
8001
75616
(3019550) Sodium [Moles/volume] in Serum or Plasma
8177
77428
1.83
43.71
17.4
16.7
mmol/l
139.7
139.7
0.29
7996
75559
(3001604) Monocytes [#/volume] in Blood
4412
37365
1.36
43.02
6.1
5.9
e9/l
0.6
0.6
2.88
3848
32064
(3048689) Calprotectin [Mass/mass] in Stool
1304
8874
1.55
42.53
2.3
2.2
ug/g
143.9
139.8
0.14
1027
6910
(3019198) Lymphocytes [#/volume] in Blood
4504
38354
1.36
41.94
6.2
5.9
e9/l
1.9
1.9
1.87
3964
33540
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1819
13400
1.45
40.01
1.3
1.3
iu/ml
32.2
36.3
0.57
572
4275
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
7890
74242
1.63
39.81
5.1
4.5
mmol/l
4.7
4.7
4.85
7306
68414
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
7795
73184
1.59
39.13
5.2
4.7
mmol/l
6.0
5.9
0.33
7123
66530
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
8010
75728
1.67
38.77
5.6
5.1
mmol/l
2.8
2.8
2.17
7367
69451
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
8309
79464
1.87
37.31
12.0
10.8
u/l
25.8
25.9
0.24
8040
76563
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
7824
73695
1.57
36.69
5.0
4.5
mmol/l
1.5
1.5
2.93
7196
67526
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1711
12648
1.44
36.49
1.3
1.3
u/ml
14.5
13.8
0.09
640
4839
(3024731) MCV [Entitic volume]
8511
82189
2.22
35.41
23.4
21.5
fl
91.1
91.2
0.76
8404
81002
(3007461) Platelets [#/volume] in Blood
8508
82154
2.21
35.31
23.5
21.5
e9/l
250.0
253.2
4.59
8307
79997
(40768797) Stomach Pathology biopsy report
1509
10956
1.46
35.30
1.3
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2957
24040
1.35
35.29
2.6
2.6
u/l
56.0
57.7
1.54
2699
22079
(3026361) Erythrocytes [#/volume] in Blood
8511
82197
2.21
35.26
23.5
21.5
e12/l
4.5
4.5
3.51
8287
79794
(3000963) Hemoglobin [Mass/volume] in Blood
8511
82212
2.21
34.99
23.6
21.6
g/l
135.3
134.5
5.70
8404
81042
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3828
32362
1.32
34.77
2.4
2.3
nmol/l
79.0
78.8
0.21
3423
28971
(3035941) MCH [Entitic mass]
8508
82186
2.19
34.74
23.4
21.4
pg
30.3
30.3
0.61
8402
80997
(3010813) Leukocytes [#/volume] in Blood
8510
82213
2.20
34.74
23.5
21.6
e9/l
6.5
6.7
6.57
8280
79804
(3013650) Neutrophils [#/volume] in Blood by Automated count
4972
43644
1.32
34.39
8.9
9.3
e9/l
3.9
4.1
8.58
4388
38015
(3015171) Extractable nuclear Ab [Units/volume] in Serum
542
3103
1.80
34.27
1.3
1.3
u/ml
1.5
1.1
0.24
40
289
(3020564) Creatinine [Moles/volume] in Serum or Plasma
8280
79305
1.79
34.08
18.1
17.1
umol/l
75.0
75.8
1.58
8275
79280
(3035350) Ketones [Presence] in Urine by Test strip
4268
36741
1.31
33.62
4.1
3.8
estimate
0.0
0.0
1.08
760
6663
(3021601) Nitrite [Presence] in Urine by Test strip
4283
36919
1.31
33.28
5.5
5.1
estimate
0.0
0.0
0.22
777
6738
(3009261) Glucose [Presence] in Urine by Test strip
4318
37303
1.31
32.83
4.2
3.8
estimate
0.0
0.0
0.05
748
6632
(3006504) Eosinophils/100 leukocytes in Blood
4077
34984
1.31
32.40
6.4
6.1
%
3.0
2.8
5.39
3795
32472
(3022096) Basophils/100 leukocytes in Blood
3964
33966
1.30
31.49
6.5
6.2
%
0.7
0.7
3.19
3695
31554
(3019069) Monocytes/100 leukocytes in Blood
4089
35192
1.30
31.40
6.7
6.4
%
8.7
8.6
0.29
3819
32835
(3018010) Neutrophils/100 leukocytes in Blood
4123
35548
1.30
31.13
6.3
6.0
%
56.7
57.2
2.29
3837
33091
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
7560
71139
1.46
30.95
4.5
4.0
mmol/l
1.3
1.3
0.49
6913
64632
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1652
12459
1.40
30.82
1.5
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3632
30818
1.30
30.80
2.9
2.8
ug/l
121.3
131.6
1.62
3334
28391
(3021960) Folate [Moles/volume] in Serum or Plasma
2235
17709
1.35
30.66
1.6
1.5
nmol/l
21.4
20.8
0.88
1913
15043
(3024561) Albumin [Mass/volume] in Serum or Plasma
3891
33346
1.30
30.52
4.7
4.8
g/l
35.8
35.5
4.20
3627
30883
(3002030) Lymphocytes/100 leukocytes in Blood
4164
36041
1.30
30.14
6.5
6.2
%
28.3
27.9
1.30
3866
33423
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4563
39995
1.29
29.87
5.7
6.3
umol/l
10.9
11.0
0.52
4320
37912
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
4919
43599
1.29
29.26
2.8
2.7
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
403
2218
1.86
28.95
1.3
1.3
u/ml
13.9
42.6
2.14
19
134
(3005322) IgE [Units/volume] in Serum or Plasma
692
4426
1.61
28.90
1.3
1.3
u/ml
268.0
200.5
0.99
637
4055
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
4436
38856
1.29
28.67
6.0
6.7
mmol/l
1.2
1.2
0.02
3756
32766
(3007853) Bacteria identified in Skin by Aerobe culture
1204
8691
1.45
28.49
1.8
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
858
5871
1.51
26.49
1.2
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
3054
25809
1.28
25.10
6.3
5.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
4932
44176
1.27
24.91
4.4
4.6
mmol/l
6.7
6.7
1.00
4617
41347
(40761511) CBC panel - Blood by Automated count
8040
77098
1.52
24.78
15.0
13.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
364
2053
1.81
24.16
1.3
1.3
u/ml
2.9
6.1
2.34
56
326
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2253
18401
1.30
23.86
2.3
2.3
mg/l
2.9
3.0
1.73
1908
15760
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
357
2031
1.79
23.03
1.3
1.3
u/ml
6.0
4.3
0.34
35
207
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
305
1666
1.86
22.47
1.3
1.2
u/ml
4.9
4.6
0.03
27
120
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
304
1661
1.86
22.38
1.2
1.2
u/ml
0.4
14.7
—
5
20
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
302
1653
1.86
22.11
1.3
1.3
u/ml
44.0
46.4
0.10
39
181
(3000570) Elastase.pancreatic [Mass/mass] in Stool
398
2364
1.72
22.09
1.4
1.4
ug/g
274.7
277.6
0.10
233
1380
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
5316
48408
1.25
21.65
3.4
3.1
u/l
47.4
49.3
0.83
4905
44845
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3991
35245
1.24
21.35
5.2
5.9
mmol/l
1.2
1.2
0.68
3583
31842
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2763
23417
1.26
21.24
2.1
2.1
u/l
159.0
208.8
3.79
2573
21889
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
160
705
2.29
21.13
1.3
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
372
2212
1.71
20.57
1.6
1.6
g/l
0.2
0.2
0.79
353
2086
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1259
9674
1.35
20.05
6.9
6.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2605
22060
1.26
19.85
2.8
2.9
ng/l
1103.4
1318.7
1.57
2192
18953
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
378
2283
1.69
19.74
1.6
1.6
g/l
1.2
1.2
0.03
360
2152
(4010399)
799
5712
1.44
19.54
1.5
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
468
2998
1.59
19.33
1.1
1.1
u/ml
1.4
1.9
—
5
45
(3011397) Hemoglobin [Presence] in Urine by Test strip
2141
17791
1.27
18.99
4.2
3.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1942
15984
1.28
18.57
4.6
4.3
kg/l
1.0
1.0
0.14
289
2409
(3019309) Folate [Moles/volume] in Red Blood Cells
1758
14303
1.29
18.42
1.7
1.7
nmol/l
1158.8
1171.5
0.24
1308
10768
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1442
11431
1.31
18.38
1.5
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
3293
28792
1.23
18.37
3.8
3.6
ng/l
118.4
61.1
0.40
2217
19860
(3044889) 12 lead EKG panel
5789
53644
1.23
18.17
4.1
3.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
3217
28091
1.23
18.09
4.4
4.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
7429
70917
1.31
17.80
14.2
13.6
ml/min/173m2
79.7
79.3
0.98
6231
58641
(3025941) Bacteria identified in Stool by Culture
596
4114
1.48
17.46
1.3
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
731
5264
1.42
17.12
1.2
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2820
24400
1.23
17.04
3.2
3.3
u/l
33.1
34.9
0.50
2649
23098
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
68
217
3.15
17.03
1.8
1.6
ug/l
9.5
8.7
0.82
68
217
(3015377) Calcium [Moles/volume] in Serum or Plasma
3040
26539
1.22
16.77
3.1
3.5
mmol/l
2.4
2.4
0.48
2607
23015
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
678
4838
1.44
16.69
1.2
1.2
iu/ml
133.6
147.6
0.47
254
1838
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2430
20763
1.24
16.40
1.7
1.6
mmol/l
1.4
1.4
0.20
2082
17306
(3020961) Endomysium IgA Ab [Titer] in Serum
489
3289
1.52
16.25
1.1
1.1
titre
126.3
199.0
0.44
16
76
(3029937) Albumin [Presence] in Urine by Test strip
2325
19791
1.24
16.22
4.6
4.3
estimate
0.0
0.0
0.03
760
6563
(3026008) Bacteria identified in Urine by Culture
2781
24127
1.22
16.16
3.5
3.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
2620
22678
1.22
15.40
3.4
3.2
mg/l
621.1
400.0
1.09
1575
13727
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
368
2355
1.59
15.30
1.6
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
3449
30704
1.20
15.08
8.6
8.7
inr
1.2
1.3
1.33
976
8643
(3009508) Creatinine [Moles/volume] in Urine
2719
23710
1.21
14.67
3.2
3.2
mmol/l
7.1
7.1
0.23
2280
19801
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1943
16381
1.24
14.55
1.7
1.7
pmol/l
79271074.0
31441717.8
1.57
1563
13495
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
608
4384
1.42
14.11
1.9
1.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
2724
23833
1.21
14.05
4.1
3.9
mg/mmol
8.0
9.0
0.62
1640
14468
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
940
7275
1.33
13.97
2.2
2.2
g/l
0.2
0.2
0.50
867
6791
(3022145) Colonoscopy Study observation
1104
8744
1.30
13.88
1.3
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1960
16635
1.23
13.66
1.7
1.7
mg/l
1.1
1.2
1.28
1491
12773
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
669
4931
1.39
13.65
2.0
1.9
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
648
4756
1.39
13.56
1.3
1.3
au/ml
62.9
54.5
—
10
214
(3039162) Centromere protein B Ab [Units/volume] in Serum
182
1001
1.84
13.28
1.3
1.3
u/ml
49.8
64.2
0.38
19
74
(3017143) Hepatitis C virus Ab [Presence] in Serum
944
7363
1.32
13.26
1.5
1.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
889
6882
1.32
13.17
2.4
2.2
nmol/l
368.1
373.2
0.33
800
6302
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
577
4182
1.41
13.00
2.4
2.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
411
2798
1.49
12.92
1.6
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1283
10450
1.27
12.86
2.0
2.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
818
6284
1.33
12.77
3.6
3.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
695
5219
1.36
12.62
2.5
2.4
au/ml
26.2
26.2
0.00
24
255
(3020717) Zinc [Moles/volume] in Serum or Plasma
85
364
2.35
12.18
1.3
1.4
umol/l
23.4
25.4
0.23
85
345
(3013512) EKG study
2567
22577
1.19
12.10
4.3
3.9
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
152
817
1.88
11.97
1.6
1.4
iu/ml
23.9
24.8
—
10
40
(3003327) Ova and parasites identified in Stool by Light microscopy
354
2384
1.51
11.76
1.7
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1883
16161
1.21
11.45
4.6
4.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
3635
33100
1.17
10.99
10.1
9.7
e9/l
0.0
0.0
0.53
3016
27012
(3018418) pH of Serum or Plasma
2630
23373
1.18
10.69
3.5
4.1
ph
7.4
7.4
0.08
457
4408
(3022948) Iron [Moles/volume] in Serum or Plasma
1389
11640
1.23
10.64
2.4
2.5
umol/l
13.2
12.8
1.17
1280
10764
(3017446) Testosterone [Moles/volume] in Serum or Plasma
540
4009
1.37
10.55
2.2
2.2
nmol/l
12.5
12.7
0.17
473
3519
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
500
3667
1.39
10.53
1.1
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
583
4384
1.35
10.49
1.6
1.9
g/l
1.4
1.3
0.08
538
3980
(3005719) IgG [Mass/volume] in Serum or Plasma
726
5637
1.31
10.49
2.6
2.8
g/l
10.7
10.4
0.78
675
5152
(3026493) Urate [Moles/volume] in Serum or Plasma
2254
19805
1.19
10.44
2.6
2.6
umol/l
2432.5
4670.2
2.81
1937
17030
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2064
17998
1.19
10.43
5.0
4.9
ug/l
2.0
3.2
2.61
1845
16179
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
727
5652
1.31
10.41
1.6
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1735
14905
1.20
10.31
3.7
3.7
ng/l
348.9
440.9
0.39
1268
11694
(3018095) Leukocytes [#/volume] in Urine
2947
26512
1.17
10.17
3.9
3.7
e6/l
95.2
106.2
0.29
2105
18525
(3004588) Protein electrophoresis panel - Serum or Plasma
684
5298
1.32
10.06
2.2
2.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
111
572
1.95
10.00
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
111
572
1.95
10.00
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
111
573
1.95
9.95
1.2
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
2353
20823
1.18
9.92
3.2
3.1
e6/l
0.3
0.4
4.56
1774
15525
(40759836) Histone Ab [Presence] in Serum by Immunoblot
110
568
1.95
9.86
1.2
1.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
120
639
1.89
9.81
1.2
1.2
u/ml
46.2
56.8
—
5
31
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
110
569
1.95
9.81
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
110
569
1.95
9.81
1.2
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
289
1941
1.51
9.79
1.1
1.1
u/ml
8.0
7.3
0.07
27
203
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
117
619
1.90
9.76
1.2
1.2
u/ml
86.4
64.8
—
7
31
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
3829
35217
1.15
9.71
4.1
4.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
163
956
1.72
9.69
1.3
1.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1281
10748
1.22
9.63
2.4
2.5
g/l
2.4
2.3
1.37
1177
9945
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
117
622
1.89
9.62
1.2
1.2
u/ml
59.8
29.8
0.87
15
47
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1515
12929
1.21
9.59
2.8
2.7
e6/l
0.8
1.5
2.25
883
7296
(3002582) Erythrocytes [#/volume] in Urine
2526
22543
1.17
9.51
3.3
3.2
e6/l
44.5
70.8
2.07
1939
17125
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
61
254
2.41
9.40
1.8
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
6936
66784
1.18
9.16
16.8
15.7
%
39.9
39.5
3.23
4606
46829
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
814
6534
1.27
9.09
2.6
2.8
ng/l
173.9
183.4
0.23
739
5953
(3009445) Proteinase 3 Ab [Units/volume] in Serum
443
3274
1.37
8.94
1.4
1.6
u/ml
7.3
16.6
—
9
87
(3019225) pH of Specimen
961
7914
1.24
8.59
4.2
4.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
109
592
1.85
8.45
1.2
1.2
u/ml
2.2
3.9
—
9
39
(3034770) Mitochondria Ab [Titer] in Serum
299
2095
1.44
8.23
1.3
1.2
titre
1147.5
895.1
0.33
12
74
(46235355) HIV 1 and 2 tests - Meaningful Use set
1172
9911
1.21
8.07
1.7
1.7
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
355
2576
1.39
8.04
1.6
1.6
titre
409.2
285.3
0.27
13
119
(3007566) Smooth muscle Ab [Titer] in Serum
298
2099
1.43
7.99
1.2
1.2
titre
102.2
141.8
0.50
27
189
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
367
2683
1.38
7.95
1.3
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1397
12033
1.19
7.87
1.8
1.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
781
6352
1.25
7.80
2.4
2.6
g/l
67.2
66.4
2.44
712
5756
(3008898) HLA-B27 [Presence]
316
2268
1.41
7.64
1.1
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1659
14538
1.17
7.61
2.8
3.0
mmol/l
2.5
2.5
1.47
1455
12725
(3000850) Epithelial cells [#/volume] in Urine
1774
15639
1.17
7.54
2.6
2.6
e6/l
5.0
6.0
2.42
1529
13672
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
356
2615
1.38
7.51
1.9
1.8
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
291
2066
1.42
7.49
1.3
1.5
iu/ml
25.4
15.9
—
6
54
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
291
2066
1.42
7.49
1.8
1.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
153
953
1.62
7.34
1.8
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
1156
9851
1.20
7.31
23.3
24.3
inr
1.3
1.3
0.97
191
1436
(36304419) Bacteria [Presence] in Urine
2251
20243
1.15
7.29
3.2
3.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
2169
19464
1.15
7.23
6.5
6.9
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
89
478
1.87
7.21
1.1
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1372
11893
1.18
7.14
3.0
2.9
e6/l
2.7
3.0
0.56
748
6308
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
88
474
1.87
7.07
1.1
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
2162
19423
1.15
7.07
3.7
3.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
459
3539
1.31
7.03
2.0
1.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1175
10067
1.19
6.99
2.4
2.6
%
22.7
22.2
0.55
966
8536
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1018
8608
1.21
6.99
1.5
1.6
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
23
66
3.49
6.97
1.0
1.2
u/ml
1.2
0.0
0.48
14
41
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
370
2773
1.35
6.90
2.4
2.3
g/l
9.9
10.1
0.54
301
2322
(3010144) Erythrocytes [#/volume] in Synovial fluid
119
708
1.69
6.85
1.5
1.4
e6/l
37766.5
107146.5
1.49
75
476
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
778
6444
1.23
6.58
2.2
2.3
ug/l
5.9
7.3
1.42
658
5609
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1626
14377
1.16
6.56
4.4
4.2
%
21.6
21.8
0.30
708
6960
(44813793)
89
495
1.81
6.50
1.1
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
6354
61242
1.14
6.47
18.6
17.8
%
13.7
13.7
1.58
6232
59949
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
170
1120
1.53
6.45
1.2
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
944
8008
1.20
6.25
1.6
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
297
2186
1.37
6.25
1.2
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
159
1043
1.53
6.17
1.3
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
295
2177
1.37
6.12
1.2
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
300
2221
1.36
6.10
1.5
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
1630
14487
1.15
6.09
2.9
2.8
mosm/kgh2o
524.7
533.5
0.92
1358
12321
(3017732) Neutrophils [#/volume] in Blood
642
5262
1.24
6.01
2.7
3.0
e9/l
4.0
4.1
0.33
471
4014
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
23
73
3.16
6.00
1.0
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1123
9709
1.18
5.99
5.1
4.6
%
32.3
32.8
0.69
743
6462
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
386
2977
1.31
5.95
2.4
2.3
g/l
7.4
7.5
0.35
288
2218
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
164
1093
1.51
5.93
1.7
1.9
pmol/l
190.8
200.9
0.65
156
1031
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
385
2970
1.31
5.93
2.4
2.3
g/l
3.8
3.8
0.07
281
2112
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
385
2973
1.31
5.89
2.4
2.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
244
1757
1.40
5.89
1.3
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
363
2788
1.32
5.78
2.4
2.3
g/l
2.9
3.1
2.25
283
2161
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
290
2155
1.36
5.78
1.2
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
70
377
1.86
5.71
1.4
1.6
ug/l
6.5
9.0
1.73
64
338
(3025159) Blasts/100 leukocytes in Blood
697
5803
1.22
5.62
3.9
4.2
%
0.1
0.4
1.78
156
1447
(3004716) Salmonella sp identified in Stool by Organism specific culture
432
3418
1.28
5.51
1.3
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
114
713
1.61
5.49
1.1
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
390
3051
1.29
5.44
5.0
5.2
%
0.9
0.9
0.08
369
2862
(3003338) MCHC [Mass/volume]
6421
62150
1.12
5.41
20.4
18.9
g/l
332.4
331.7
6.48
6382
61733
(3024980) IgG subclass 4 [Mass/volume] in Serum
174
1200
1.46
5.36
1.8
1.6
g/l
0.6
0.7
1.24
132
891
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
152
1021
1.50
5.34
1.3
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
392
3080
1.29
5.29
4.9
5.2
%
1.7
1.6
0.34
371
2884
(3025468) Yersinia sp identified in Specimen by Organism specific culture
151
1016
1.49
5.27
1.3
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
704
5907
1.21
5.26
3.8
4.0
%
0.7
0.6
0.52
145
1337
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
412
3261
1.28
5.25
2.1
1.9
u/l
40.2
39.2
0.41
353
2865
(4062490)
119
762
1.57
5.21
1.7
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
143
954
1.51
5.20
1.7
1.6
%
60.0
57.5
0.30
84
584
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
977
8448
1.18
5.20
4.0
4.3
u/l
231.2
245.5
3.88
910
7973
(3023520) Reticulocytes [#/volume] in Blood
733
6181
1.20
5.20
2.6
2.6
e9/l
71.0
70.2
0.24
563
4649
(3005988) Vibrio sp identified in Specimen by Organism specific culture
151
1020
1.49
5.18
1.3
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
254
1884
1.36
5.17
1.7
1.6
e6/l
13625.3
12492.5
0.18
181
1353
(3024522) Salmonella sp identified in Specimen by Organism specific culture
152
1029
1.49
5.16
1.3
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
276
2077
1.34
5.11
1.5
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
959
8297
1.17
5.07
1.7
1.8
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
150
1017
1.48
5.06
1.3
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
957
8281
1.17
5.05
1.8
1.8
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
272
2050
1.34
4.99
2.2
2.0
mg/l
10.4
11.4
1.33
248
1890
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
36
160
2.26
4.96
3.1
2.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
568
4701
1.22
4.89
5.8
7.0
mmol/l
24.4
24.7
0.99
529
4374
(3000492) Spirometry study
818
7015
1.18
4.81
1.5
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
197
1420
1.40
4.80
1.3
1.3
u/l
11.3
12.3
0.47
160
1144
(3047181) Lactate [Moles/volume] in Blood
308
2380
1.30
4.76
5.4
6.1
mmol/l
1.3
1.3
0.01
277
2101
(3017181) Myelocytes/100 leukocytes in Blood
761
6493
1.19
4.75
4.0
4.1
%
1.0
0.9
0.30
186
1864
(3024139) IgG subclass 3 [Mass/volume] in Serum
117
764
1.54
4.74
1.7
1.4
g/l
0.4
0.4
0.80
90
523
(3028192) IgG subclass 2 [Mass/volume] in Serum
117
764
1.54
4.74
1.7
1.4
g/l
3.1
2.8
0.62
87
522
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
581
4846
1.21
4.64
3.2
3.3
pmol/l
4.4
4.4
0.69
507
4284
(3027945) Reticulocytes/100 erythrocytes in Blood
940
8180
1.17
4.62
2.5
2.5
%
1.8
1.8
0.33
830
7249
(3012494) Peanut IgE Ab [Units/volume] in Serum
35
159
2.21
4.60
1.1
1.1
u/ml
1.5
1.3
0.06
16
77
(3027135) IgG subclass 1 [Mass/volume] in Serum
116
764
1.53
4.54
1.7
1.4
g/l
6.7
6.8
0.15
87
522
(3021440) Promyelocytes/100 leukocytes in Blood
724
6177
1.19
4.53
4.0
4.2
%
0.1
0.1
0.10
177
1730
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
918
7991
1.17
4.50
1.7
1.7
%
1.5
1.5
0.62
810
6946
(3019832) Treponema pallidum Ab [Presence] in Serum
486
4002
1.23
4.42
1.6
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
288
2231
1.30
4.40
1.6
1.6
iu/ml
0.2
4.5
0.90
54
488
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
298
2327
1.29
4.29
2.2
2.2
g/l
38.5
37.7
1.49
255
1984
(3023368) Bacteria identified in Blood by Culture
2170
20022
1.11
4.28
4.2
4.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
631
5353
1.19
4.23
1.4
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
997
8781
1.15
4.18
2.3
2.7
umol/l
6.9
8.2
1.85
855
7604
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1393
12564
1.13
4.08
2.9
3.2
mmol/l
0.8
0.8
0.13
1291
11715
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
142
999
1.43
4.04
1.8
2.1
mg/l
32.7
25.0
0.73
32
256
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
49
268
1.83
3.93
1.2
1.3
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
40
206
1.95
3.85
2.0
1.9
mg/l
9.2
9.4
0.07
33
165
(3033923) Metanephrine [Moles/time] in 24 hour Urine
35
173
2.03
3.78
1.0
1.2
umol/24h
0.6
0.7
0.33
14
77
(3013945) Hepatitis B virus e Ab [Presence] in Serum
12
34
3.53
3.76
1.0
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
590
5034
1.18
3.73
3.2
3.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
454
3784
1.21
3.72
2.7
2.7
e6/l
0.3
0.3
0.30
437
3682
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
44
239
1.85
3.63
1.3
1.2
g/l
0.3
0.3
0.13
31
190
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
714
6204
1.16
3.62
2.5
2.7
ml/min/173m2
65.3
64.6
0.23
300
2459
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1085
9711
1.13
3.60
5.0
5.7
mmol/l
1.0
1.0
2.98
1014
9032
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
246
1927
1.28
3.53
1.4
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
316
2556
1.25
3.47
1.4
1.3
iu/l
29.5
35.1
2.49
283
2194
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
86
567
1.52
3.45
1.1
1.0
mg/l
284.2
290.1
0.33
79
505
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
262
2077
1.27
3.43
2.3
2.3
g/l
0.0
0.0
0.34
244
1884
(3019060) Gas panel - Arterial blood
577
4955
1.18
3.41
4.3
4.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
91
609
1.50
3.41
1.3
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
257
2041
1.27
3.32
2.4
2.3
g/l
0.0
0.0
0.00
240
1880
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
71
454
1.57
3.28
1.1
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
232
1827
1.28
3.23
1.2
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
71
456
1.56
3.22
1.1
1.1
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
23
103
2.24
3.21
1.2
1.2
—
95.3
—
0
6
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
12
38
3.16
3.21
1.8
1.4
mg/l
0.1
0.8
—
5
23
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
12
38
3.16
3.21
1.8
1.4
mg/l
1.2
2.4
—
6
25
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
12
38
3.16
3.21
1.8
1.4
mg/l
4.3
0.7
—
6
24
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
12
38
3.16
3.21
1.8
1.4
mg/l
0.6
2.0
—
6
28
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
12
38
3.16
3.21
1.8
1.4
mg/l
5.8
2.0
—
5
22
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
12
38
3.16
3.21
1.8
1.4
mg/l
2.5
3.6
—
5
24
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
12
38
3.16
3.21
1.8
1.4
mg/l
1.0
3.4
—
5
26
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
12
38
3.16
3.21
1.8
1.4
mg/l
0.4
1.4
—
6
25
(3006922) Hepatitis E virus Ab [Presence] in Serum
76
497
1.53
3.19
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
343
2833
1.22
3.13
1.9
1.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
276
2229
1.25
3.11
2.3
2.3
g/l
0.0
0.0
0.02
257
2031
(3029075) Extractable nuclear Ab panel - Serum
38
208
1.83
3.11
1.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
64
406
1.58
3.08
1.3
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
185
1428
1.30
3.03
1.7
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
217
1712
1.27
3.00
1.8
1.7
mu/l
287.2
303.4
0.42
198
1546
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
87
594
1.47
3.00
1.3
1.2
titre
198.0
143.2
0.28
15
111
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
77
516
1.50
2.92
1.9
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
369
3094
1.20
2.91
2.0
2.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
308
2539
1.22
2.89
2.3
2.4
g/l
1.0
0.8
0.34
269
2171
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
49
297
1.65
2.85
3.5
2.7
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
32
171
1.87
2.84
2.5
1.9
ug/l
1.4
2.3
2.22
16
95
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
36
200
1.80
2.84
1.3
1.3
%
36.1
35.4
0.04
21
132
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
135
1007
1.35
2.83
1.1
1.1
—
—
—
0
0
(3039000) Anion gap in Blood
214
1701
1.26
2.81
6.4
7.1
mmol/l
11.2
11.2
0.04
195
1528
(3018572) Chloride [Moles/volume] in Blood
214
1702
1.26
2.80
6.4
7.1
mmol/l
105.3
105.0
0.30
195
1529
(3000093) Morphology [Interpretation] in Blood Narrative
96
679
1.42
2.78
1.1
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
16
66
2.43
2.70
1.1
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
119
879
1.36
2.68
1.1
1.1
u/ml
1.7
1.9
0.06
30
192
(3002173) Hemoglobin [Mass/volume] in Arterial blood
793
7102
1.13
2.65
7.0
7.9
g/l
121.6
120.6
0.74
761
6841
(3047007) Chlamydophila sp Ab [Presence] in Serum
130
977
1.34
2.62
1.3
1.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
53
336
1.58
2.61
1.1
1.0
u/ml
14.5
1.7
0.42
15
93
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
98
705
1.39
2.60
1.5
1.5
%
26.8
31.1
0.56
55
411
(3023430) Cat dander IgE Ab [Units/volume] in Serum
99
714
1.39
2.59
1.1
1.0
u/ml
5.4
3.4
0.34
42
255
(3016502) Oxygen saturation in Arterial blood
851
7668
1.12
2.57
6.6
7.5
%
96.3
95.7
3.49
815
7376
(3017704) Immunofixation for Urine
61
401
1.52
2.57
1.8
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
152
1172
1.30
2.56
1.1
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
490
4259
1.16
2.56
1.4
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
156
1208
1.30
2.55
1.4
1.4
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
5
7
7.14
2.55
1.6
1.6
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
56
362
1.55
2.55
2.6
2.7
—
31.4
—
0
5
(3014599) Egg white IgE Ab [Units/volume] in Serum
51
323
1.58
2.53
1.0
1.0
u/ml
6.3
0.5
—
10
71
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
107
785
1.37
2.53
1.2
1.1
—
2.2
—
0
9
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
684
6092
1.13
2.51
3.1
3.6
ng/l
85.6
89.4
0.51
576
5189
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
239
1954
1.23
2.48
1.3
1.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
69
470
1.47
2.47
1.3
1.6
u/l
5.1
6.5
1.71
60
394
(3014133) Dog dander IgE Ab [Units/volume] in Serum
104
763
1.37
2.47
1.1
1.1
u/ml
1.0
3.5
3.62
43
272
(3011412) CD3 cells [#/volume] in Blood
97
704
1.38
2.46
2.1
2.3
e9/l
1.2
1.1
0.22
65
416
(3045716) Anion gap in Serum or Plasma
53
342
1.55
2.44
2.4
2.4
mmol/l
8.4
9.3
1.36
36
257
(3002621) Streptococcal DNAse B [Units/volume] in Serum
13
51
2.55
2.44
1.1
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
78
546
1.43
2.43
1.9
2.0
%
15.2
14.6
0.13
36
223
(3049717) Cytology report of Urine Cyto stain
314
2644
1.19
2.42
2.4
2.6
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
21
103
2.04
2.41
1.0
1.0
ug/l
91.4
79.0
0.50
15
83
(3027696) Helicobacter pylori Ab [Titer] in Serum
5
8
6.25
2.37
1.0
1.1
titre
1076.0
1477.5
—
5
8
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
66
450
1.47
2.37
1.1
1.1
iu/ml
4.4
10.8
2.73
15
109
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
12
46
2.61
2.35
1.1
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
169
1339
1.27
2.34
1.1
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
542
4780
1.14
2.33
1.4
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
98
722
1.36
2.29
3.8
3.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
940
8580
1.11
2.27
6.4
7.1
mmol/l
1.0
1.1
0.25
723
6760
(3052592) Norovirus Ag [Presence] in Stool
27
149
1.81
2.23
1.1
1.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
114
864
1.32
2.22
1.4
1.4
u/l
37.1
32.7
0.61
97
693
(3052851) Hemolysis interference index of Serum or Plasma
278
2337
1.20
2.22
2.7
3.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
155
1225
1.27
2.21
1.8
1.4
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
5
9
5.56
2.21
1.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
36
218
1.65
2.17
1.2
1.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
76
542
1.41
2.17
1.8
1.7
umol/l
10.8
8.5
0.37
58
382
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
23
122
1.89
2.15
1.1
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
221
1827
1.22
2.12
2.4
2.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
60
412
1.46
2.11
1.1
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
463
4073
1.14
2.10
8.2
9.6
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
35
213
1.65
2.09
1.6
1.6
ug/l
0.5
0.4
0.90
22
137
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
16
75
2.14
2.08
1.1
1.0
u/ml
0.5
1.4
—
10
52
(3027273) Bicarbonate [Moles/volume] in Venous blood
399
3478
1.15
2.06
3.6
3.4
mmol/l
25.3
25.3
0.09
388
3386
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
19
96
1.98
2.04
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
33
199
1.66
2.04
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
74
533
1.39
2.02
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
56
383
1.47
2.02
1.1
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
129
1010
1.28
2.01
1.1
1.1
g/l
1.5
1.5
0.79
118
901
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
81
593
1.37
2.01
1.4
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
443
3899
1.14
2.01
4.4
3.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
74
536
1.38
1.97
1.2
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
203
1679
1.21
1.96
2.6
2.2
g/l
130.4
128.2
0.60
144
1179
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
51
345
1.48
1.96
1.4
1.2
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
65
461
1.41
1.95
2.2
2.6
e9/l
0.2
0.2
0.03
60
396
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
935
8601
1.10
1.95
6.4
7.1
kpa
5.1
5.1
0.28
886
8213
(3044927) Protein electrophoresis panel - Urine
103
787
1.31
1.94
1.2
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
8
27
2.96
1.93
1.0
1.0
—
—
—
0
0
(4038314)
6
16
3.75
1.93
1.5
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
54
371
1.46
1.92
1.0
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
712
6467
1.11
1.92
6.0
7.4
mmol/l
8.8
9.8
3.52
669
6177
(3043410) Blood group antigens tested for on Red Blood Cells
32
195
1.64
1.92
1.3
1.8
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
40
258
1.55
1.91
1.4
1.3
umol/l
3.7
3.7
0.01
35
240
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
193
1593
1.22
1.91
1.2
1.3
mmol/l
3.8
3.8
0.20
180
1496
(4281824)
76
1026
0.74
1.90
1.2
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
300
2578
1.17
1.90
2.5
3.0
g/l
0.4
0.3
0.83
118
999
(3028679) Herpes simplex virus Ab [Presence] in Serum
48
323
1.49
1.90
1.1
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
27
158
1.71
1.88
1.0
1.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
933
8600
1.09
1.87
6.4
7.1
kpa
12.6
12.4
0.53
885
8210
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
21
114
1.84
1.86
1.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
72
525
1.37
1.86
1.2
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
127
1006
1.27
1.84
1.0
1.1
u/ml
5.6
4.1
0.38
63
474
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
84
629
1.34
1.84
1.1
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
67
484
1.39
1.83
2.1
2.5
e6/l
469.6
511.2
0.36
61
402
(3003721) Smooth muscle Ab [Units/volume] in Serum
10
40
2.50
1.83
1.1
1.3
—
1.2
—
0
7
(3046682) IgA [Presence] in Skin by Immunofluorescence
5
12
4.17
1.82
1.0
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
102
789
1.30
1.79
3.6
3.6
%
58.3
57.6
0.14
65
506
(3016650) Hepatitis A virus Ab [Presence] in Serum
142
1147
1.24
1.75
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
56
396
1.42
1.74
1.1
1.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1232
11531
1.08
1.73
1.9
2.1
s
29.7
29.7
0.14
1188
11188
(4094501)
246
2099
1.18
1.73
1.1
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
52
731
0.71
1.71
1.0
1.0
—
—
—
0
0
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
10
42
2.38
1.67
1.0
1.1
u/ml
0.1
0.1
—
5
21
(3008757) Leukocyte morphology finding [Identifier] in Blood
104
815
1.28
1.67
3.9
4.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
145
1182
1.23
1.66
1.6
1.7
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
6
19
3.16
1.66
1.2
1.2
%
1.7
3.1
—
6
19
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
87
667
1.31
1.65
1.3
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
68
503
1.35
1.64
1.3
1.3
u/ml
0.7
1.0
0.25
26
250
(1002224) Polysomnography panel
321
2811
1.15
1.62
1.1
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
32
205
1.56
1.61
3.3
2.9
mg/l
7.7
7.8
0.02
23
165
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
56
403
1.39
1.60
2.3
2.9
%
38.7
38.9
0.03
32
143
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
17
91
1.87
1.60
1.5
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
190
1602
1.19
1.56
1.3
1.4
e6/l
22.8
33.4
0.35
140
1244
(3045424) Erythrocytes [Presence] in Urine
160
1329
1.21
1.55
1.4
1.5
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
190
1604
1.19
1.54
1.4
1.4
e6/l
838.4
1448.7
0.74
151
1307
(3012544) pH of Venous blood
753
6942
1.09
1.54
3.5
3.8
ph
7.4
7.4
—
7
35
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
19
107
1.78
1.54
1.2
1.5
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
24
145
1.66
1.53
1.1
1.3
mg/l
0.5
48.0
0.73
15
106
(3038177) Helicobacter pylori Ab [Presence] in Serum
142
1167
1.22
1.53
1.3
1.2
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
52
373
1.40
1.53
1.6
1.5
%
3.1
3.9
—
9
79
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
532
5856
0.90
1.53
1.7
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
223
1911
1.17
1.52
5.4
4.3
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
43
298
1.45
1.52
2.1
2.2
ug/l
25.1
213.2
0.93
37
277
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
213
1819
1.18
1.52
1.3
1.3
mg/l
506.7
551.3
0.77
201
1727
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
781
7221
1.09
1.51
2.4
2.4
u/l
40.2
44.2
0.17
659
6155
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
6
21
2.86
1.50
1.0
1.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
77
590
1.31
1.49
1.9
2.2
%
49.5
41.6
0.82
12
76
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
176
1481
1.19
1.49
1.6
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
154
1280
1.21
1.49
3.0
2.8
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
71
540
1.32
1.46
1.3
1.4
mmol/l
2.0
2.1
1.08
65
508
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
48
343
1.40
1.45
1.2
1.3
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
25
157
1.59
1.40
1.7
1.6
ng/l
112.4
112.8
0.01
25
157
(3045683) HLA typing for celiac disease panel - Blood or Tissue
54
397
1.36
1.40
1.1
1.0
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
31
205
1.51
1.39
1.0
1.1
%
84.0
89.5
0.33
16
98
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
135
1117
1.21
1.39
1.1
1.1
u/ml
2.5
1.4
0.39
55
412
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
378
3386
1.12
1.39
1.7
1.6
g/l
1.5
1.6
1.87
323
2905
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
11
53
2.08
1.38
1.0
1.0
u/ml
0.6
0.2
—
5
34
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1916
18340
1.06
1.38
2.3
2.3
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
40
280
1.43
1.37
1.6
1.5
pmol/l
15.2
15.9
0.40
34
236
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
290
2559
1.14
1.36
2.4
2.3
ug/l
237.4
607.7
3.12
272
2408
(3009466) Valproate [Moles/volume] in Serum or Plasma
80
1015
0.79
1.36
3.1
5.1
umol/l
350.6
363.6
0.30
64
875
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
343
3836
0.89
1.35
1.5
1.5
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
37
0.00
1.34
0.0
1.2
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
38
0.00
1.34
0.0
3.4
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
40
0.00
1.32
0.0
12.7
—
371.3
—
0
31
(40768441) Liver Pathology biopsy report
73
567
1.29
1.32
1.3
1.3
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
41
0.00
1.31
0.0
4.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
118
971
1.22
1.30
1.0
1.1
u/ml
1.3
1.2
0.10
53
376
(21494434) Karyotype in Bone marrow
82
648
1.27
1.30
1.1
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
490
4472
1.10
1.29
1.8
1.7
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
28
185
1.52
1.28
1.3
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
48
352
1.37
1.28
1.1
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
10
48
2.08
1.27
1.1
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
11
55
2.00
1.27
1.1
1.2
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
30
202
1.49
1.26
1.0
1.2
%
89.4
89.2
0.01
15
101
(3042517) Benzodiazepines panel - Urine
9
44
2.05
1.26
1.2
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
48
353
1.36
1.26
1.5
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
48
353
1.36
1.26
1.5
1.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
177
1517
1.17
1.26
2.9
2.8
kpa
8.1
8.1
0.17
161
1402
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
494
4518
1.10
1.25
3.3
3.5
kpa
5.1
5.2
1.00
449
4174
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
24
154
1.56
1.25
1.2
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
53
397
1.34
1.25
1.3
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
53
397
1.34
1.25
1.3
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
13
70
1.86
1.23
2.5
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
205
1782
1.15
1.22
2.9
3.1
mmol/l
24.5
25.0
0.97
171
1550
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
207
1801
1.15
1.22
1.5
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
203
1764
1.15
1.22
1.3
1.3
miu/ml
215.2
215.3
0.00
86
786
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
14
78
1.80
1.21
1.0
1.2
umol/24h
1.7
1.7
0.02
14
78
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
75
593
1.27
1.20
1.3
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1097
10375
1.07
1.20
3.0
3.0
ug/l
0.7
0.8
0.03
693
6890
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
81
648
1.25
1.18
1.0
1.0
u/ml
0.5
0.5
0.02
16
135
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
8
38
2.11
1.18
1.1
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
8
38
2.11
1.18
1.0
1.7
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
25
165
1.52
1.17
1.4
1.4
g/l
24.1
26.4
0.29
19
128
(3023419) Bacteria identified in Sputum by Culture
114
949
1.20
1.15
2.5
2.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
179
1550
1.16
1.14
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
179
1550
1.16
1.14
1.3
1.3
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
36
0.00
1.14
0.0
1.0
—
112.3
—
0
19
(3004119) Hemoglobin [Mass/volume] in Venous blood
482
4428
1.09
1.13
3.4
3.3
g/l
128.6
128.3
0.10
471
4322
(3033658) Prothrombin time (PT) actual/Normal
2014
19404
1.05
1.13
3.8
3.9
%
92.3
91.2
1.09
1947
18926
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
16
95
1.69
1.13
1.0
1.4
nmol/l
4.3
413931.8
0.91
11
79
(3014576) Chloride [Moles/volume] in Serum or Plasma
995
9403
1.07
1.12
6.2
6.9
mmol/l
104.5
104.3
0.71
972
9192
(3036048) Francisella tularensis Ab [Titer] in Serum
24
159
1.51
1.11
1.0
1.1
—
253.3
—
0
6
(3010503) CD19 cells [#/volume] in Blood
60
468
1.28
1.09
2.4
2.5
e9/l
0.2
0.4
0.75
60
451
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
275
2461
1.12
1.09
3.2
3.4
mg/l
48.6
48.3
0.01
230
1994
(3034860) Kappa light chains.free [Mass/volume] in Serum
275
2461
1.12
1.09
3.2
3.4
mg/l
44.2
76.2
0.75
227
1992
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
53
407
1.30
1.08
1.1
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
484
4459
1.09
1.08
3.4
3.5
ph
7.4
7.4
0.54
69
568
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
244
2169
1.13
1.08
1.7
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
244
2171
1.13
1.07
1.8
1.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
32
228
1.40
1.05
1.5
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
96
795
1.21
1.05
1.2
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
712
6674
1.07
1.04
3.4
3.8
kpa
5.8
5.8
0.35
696
6494
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
267
2394
1.12
1.03
3.2
3.3
ratio
2.5
1.9
0.22
16
189
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
5
22
2.27
1.03
1.2
1.5
nmol/l
562.9
531.4
—
5
22
(40761536) Microorganisms panel - Urine sediment
672
6288
1.07
1.03
4.4
4.1
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
8
150
0.53
1.02
1.5
1.8
mmol/l
1.2
1.2
—
8
145
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
465
4291
1.09
1.02
3.3
3.4
mmol/l
1.5
1.8
1.29
348
3235
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
181
1586
1.14
1.01
1.6
1.5
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
79
644
1.23
1.01
1.1
1.1
nmol/l
395.0
355.5
0.75
54
551
(40765096) Chromosome analysis panel by Banding
30
213
1.41
1.01
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
110
927
1.19
1.01
1.1
1.1
u/ml
2.9
3.4
0.25
33
397
(3001686) Cold agglutinin [Titer] in Serum or Plasma
22
147
1.50
1.00
1.3
1.4
—
196.0
—
0
23
(4034850)
273
2457
1.11
1.00
10.6
9.7
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
103
864
1.19
1.00
2.4
2.9
%
13.4
13.2
0.73
103
851
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
5
23
2.17
0.98
1.0
1.0
—
—
—
0
0
(3036603) Volume of Urine
65
521
1.25
0.98
1.4
1.6
ml
1496.5
1834.1
0.80
13
130
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
38
283
1.34
0.98
1.2
1.1
miu/ml
1512.1
1542.7
0.06
38
283
(21494814) CD8 cells/100 lymphocytes in Specimen
41
309
1.33
0.98
2.1
1.9
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
104
1231
0.84
0.97
1.3
1.2
u/ml
281.1
287.0
0.08
61
774
(3011325) HIV 1+2 Ab [Presence] in Serum
0
30
0.00
0.97
0.0
1.0
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
7
36
1.95
0.97
2.1
1.7
—
0.1
—
0
9
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
40
301
1.33
0.96
1.1
1.1
ng/l
86.0
349.5
—
10
70
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
9
50
1.80
0.96
1.7
2.1
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
0
31
0.00
0.96
0.0
5.0
—
16.9
—
0
26
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
88
731
1.21
0.95
1.1
1.1
—
79.3
—
0
11
(3023511) Choriogonadotropin [Units/volume] in Urine
84
695
1.21
0.95
1.3
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
134
1156
1.16
0.94
1.3
1.4
—
—
—
0
0
(3020891) Body temperature
329
3002
1.10
0.94
3.6
4.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
153
1334
1.15
0.94
1.4
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
16
101
1.59
0.93
1.0
1.1
—
—
—
0
0
(4015189)
30
217
1.38
0.93
3.1
2.2
—
—
—
0
0
(3019977) pH of Arterial blood
54
427
1.27
0.92
2.1
2.9
ph
7.4
7.4
0.81
18
145
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
107
909
1.18
0.92
1.2
1.2
u/l
60.4
62.0
0.09
70
617
(3004451) EKG impression Narrative
48
374
1.28
0.92
1.4
1.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
65
526
1.24
0.91
1.5
1.9
mmol/l
6.9
6.8
0.04
39
355
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
124
1437
0.86
0.91
1.5
1.5
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
28
2.14
0.91
1.0
1.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
252
2274
1.11
0.90
3.3
4.2
mmol/l
3.8
3.9
0.18
240
2133
(3028707) Methadone [Presence] in Urine by Screen method
90
755
1.19
0.89
1.9
2.9
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
94
792
1.19
0.89
1.8
2.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
291
2648
1.10
0.89
3.1
4.0
mmol/l
1.4
1.3
0.18
286
2603
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
98
829
1.18
0.89
1.6
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
181
1604
1.13
0.89
1.8
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
113
1315
0.86
0.89
1.3
1.2
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
33
245
1.35
0.88
1.2
1.2
g/l
39.2
38.7
0.05
16
131
(3023410) Appearance of Cerebral spinal fluid
87
729
1.20
0.88
1.3
1.5
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
57
457
1.25
0.88
1.1
1.1
nmol/l
1.0
9.1
—
9
89
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
111
951
1.17
0.87
1.2
1.2
mmol/l
7.7
7.4
0.25
87
707
(3002032) Base excess in Venous blood by calculation
707
6675
1.06
0.87
3.4
3.8
mmol/l
1.9
2.0
0.47
581
5466
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
121
1045
1.16
0.86
1.4
1.3
nmol/l
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
11
64
1.72
0.86
1.8
1.4
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
50
396
1.26
0.86
1.7
1.4
nmol/l
1.4
1.2
0.66
45
305
(3035637) Corticotropin [Mass/volume] in Plasma
109
935
1.17
0.85
1.6
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
1055
10087
1.05
0.84
1.3
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
29
213
1.36
0.84
1.3
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
142
1616
0.88
0.83
4.3
3.5
mg/l
19.2
27.1
2.72
88
992
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
39
301
1.30
0.82
1.1
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
169
1501
1.13
0.82
3.3
2.8
umol/l
33.0
33.9
0.20
143
1291
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
51
408
1.25
0.81
1.3
1.1
ratio
1.1
1.1
0.46
20
145
(3016228) CD19 cells/100 cells in Blood
41
319
1.29
0.81
2.1
1.9
%
7.7
8.5
0.16
41
309
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
214
1929
1.11
0.81
1.8
1.8
iu/l
4.9
9.3
0.47
72
688
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
38
293
1.30
0.81
1.9
2.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
145
1277
1.14
0.80
1.7
1.5
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
8
47
1.70
0.80
1.3
1.8
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
88
747
1.18
0.79
1.7
1.7
titre
10416.0
1084.4
—
5
27
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
191
1715
1.12
0.78
1.6
1.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
15
223
0.67
0.78
4.0
4.9
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
49
607
0.81
0.78
1.7
1.7
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
56
682
0.82
0.76
2.6
2.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
33
252
1.31
0.76
1.9
1.9
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
28
0.00
0.76
0.0
5.5
—
393.5
—
0
28
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
193
1738
1.11
0.76
1.6
1.6
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
43
341
1.26
0.75
5.3
5.0
u/ml
1794.7
582.7
—
10
58
(3050129) First trimester maternal screen panel - Serum or Plasma
78
919
0.85
0.75
1.3
1.4
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
38
297
1.28
0.75
1.4
5.1
mg/l
70.9
749.3
0.48
25
211
(40761539) Cells [Type] in Urine sediment by Light microscopy
26
192
1.36
0.74
1.2
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
43
342
1.26
0.74
1.7
1.6
nmol/l
5.8
5.2
0.08
31
277
(3000012) Reticulocyte production index
49
396
1.24
0.74
1.4
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
82
698
1.18
0.73
1.4
1.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
44
352
1.25
0.72
1.5
2.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
146
1298
1.13
0.72
1.6
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
73
616
1.19
0.72
1.1
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
14
92
1.52
0.72
1.0
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
207
1878
1.10
0.72
2.2
2.9
mg/l
1.5
1.6
0.93
187
1720
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
52
425
1.22
0.71
1.3
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
155
1385
1.12
0.71
1.4
1.4
mmol/l
59.0
62.9
0.65
121
1104
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
14
206
0.68
0.71
1.9
1.8
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
21
151
1.39
0.71
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
20
275
0.73
0.70
1.1
1.1
—
—
—
0
0
(4146454)
97
841
1.16
0.70
3.1
2.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
823
7867
1.05
0.69
3.1
3.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
93
805
1.16
0.69
3.3
13.4
mmol/l
7.6
7.5
0.03
79
665
(3044290) Cell count panel - Cerebral spinal fluid
165
1484
1.11
0.68
1.2
1.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
16
110
1.46
0.68
1.0
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
49
401
1.22
0.67
1.6
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
49
401
1.22
0.67
1.6
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
49
401
1.22
0.67
1.6
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
2464
24088
1.03
0.67
2.3
2.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
51
420
1.22
0.66
1.3
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
49
402
1.22
0.66
1.6
2.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
55
658
0.83
0.65
1.7
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
57
476
1.20
0.65
1.3
1.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
133
1186
1.12
0.65
1.4
1.3
nmol/l
0.6
2.0
0.69
126
1140
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
17
120
1.42
0.64
10.6
7.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
41
504
0.81
0.64
1.2
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
96
839
1.15
0.64
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
138
1235
1.12
0.64
1.3
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
112
990
1.13
0.63
4.2
6.8
mg/l
11.1
11.9
1.03
101
910
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
115
1019
1.13
0.63
1.4
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
15
104
1.44
0.62
1.2
1.4
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
22
164
1.34
0.62
1.4
2.1
e6/l
164.6
148.3
0.17
13
78
(3032868) Hemoglobin electrophoresis panel in Blood
10
63
1.59
0.61
1.6
1.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
14
96
1.46
0.61
1.1
1.1
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
8
50
1.60
0.61
1.1
1.1
u/l
—
4.3
—
0
12
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
25
191
1.31
0.60
1.2
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
70
813
0.86
0.60
1.5
1.5
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.0
—
11360.5
—
0
6
(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method
0
21
0.00
0.60
0.0
1.0
—
0.9
—
0
12
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
272
2527
1.08
0.59
1.9
1.7
mg/l
4.8
3.6
0.71
200
1814
(4035726)
755
7237
1.05
0.59
1.4
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
20
266
0.75
0.59
1.4
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
680
6503
1.05
0.59
3.4
3.9
mmol/l
1.2
1.2
0.13
605
5672
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
87
761
1.14
0.59
1.1
1.1
—
4.0
—
0
9
(3003434) Protein [Mass/volume] in Pleural fluid
83
949
0.87
0.58
1.6
1.5
g/l
34.3
32.8
0.46
73
856
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
16
220
0.73
0.58
1.2
1.2
—
—
—
0
0
(37019676) Renin [Units/volume] in Plasma --supine
0
23
0.00
0.58
0.0
1.1
—
17.7
—
0
13
(44806071)
13
89
1.46
0.57
1.1
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
115
0.61
0.57
1.0
1.3
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
51
428
1.19
0.57
1.1
1.1
u/l
15.9
25.2
1.70
39
318
(3028308) Erythrocytes [#/volume] in Pleural fluid
65
755
0.86
0.57
1.6
1.4
e6/l
72143.0
55857.6
0.16
39
438
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
302
2824
1.07
0.56
3.5
3.7
mmol/l
24.7
25.0
0.86
282
2588
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
273
2544
1.08
0.56
2.7
2.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
49
411
1.19
0.56
1.1
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
572
5459
1.05
0.55
2.9
3.1
kpa
4.5
4.6
0.44
555
5293
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
240
2229
1.08
0.54
1.2
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
19
142
1.34
0.54
1.5
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
172
1576
1.09
0.54
2.9
2.5
%
16.1
16.2
0.09
93
791
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
137
1510
0.91
0.54
2.5
2.9
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
56
654
0.86
0.53
1.3
1.2
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
9
61
1.48
0.53
1.1
1.1
u/l
6.3
15.1
—
9
61
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
9
61
1.48
0.53
4.3
6.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
149
1357
1.10
0.53
1.3
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
58
497
1.17
0.53
2.3
2.6
e6/l
775.9
679.3
0.37
27
218
(40758358) Immune stain study
6
39
1.54
0.53
1.0
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
15
108
1.39
0.53
1.8
1.4
%
37.0
52.7
—
8
49
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
9
62
1.45
0.53
1.1
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
24
305
0.79
0.52
1.1
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
75
656
1.14
0.52
1.2
1.3
nmol/l
1.6
1.5
0.37
64
596
(3022313) Gas panel - Capillary blood
344
3242
1.06
0.52
3.3
3.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
35
286
1.22
0.52
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
32
259
1.24
0.52
1.2
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
83
1.45
0.51
1.0
1.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
95
846
1.12
0.51
1.2
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
140
1275
1.10
0.51
4.2
3.5
%
1.4
1.5
0.20
103
989
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
45
379
1.19
0.50
1.4
1.7
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
6
41
1.46
0.50
1.0
1.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
74
840
0.88
0.49
1.6
1.4
e6/l
1536.4
2282.3
1.40
53
609
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
43
508
0.85
0.49
1.7
1.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
45
381
1.18
0.48
3.2
2.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
119
1080
1.10
0.47
1.3
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
7
47
1.49
0.47
4.9
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
374
3938
0.95
0.46
9.0
9.0
mmol/l
24.3
24.4
0.18
343
3686
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
7
48
1.46
0.46
1.1
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
165
1523
1.08
0.46
2.8
3.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
112
1015
1.10
0.46
1.3
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
22
173
1.27
0.46
9.1
7.8
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
88
787
1.12
0.46
1.7
1.4
mosm/kgh2o
277.9
278.0
0.01
65
600
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
50
430
1.16
0.46
1.1
1.1
u/l
79.6
85.9
0.32
39
327
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
17
129
1.32
0.45
1.1
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
14
187
0.75
0.45
1.4
1.3
mu/l
12.9
74.1
—
8
139
(3017315) Amylase [Enzymatic activity/volume] in Urine
48
412
1.17
0.45
1.1
1.3
u/l
361.4
295.9
0.13
39
383
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
116
1056
1.10
0.44
1.5
1.4
—
—
—
0
0
(4024509)
91
818
1.11
0.44
1.8
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
193
2071
0.93
0.44
1.2
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
85
947
0.90
0.44
1.0
1.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
131
1201
1.09
0.44
2.0
1.9
mmol/l
1.6
1.7
0.18
131
1173
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
28
229
1.22
0.43
3.0
3.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
109
991
1.10
0.43
1.1
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
9
128
0.70
0.43
2.7
3.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
24
193
1.24
0.43
1.2
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
24
193
1.24
0.43
1.3
1.4
g/l
9.8
12.7
0.99
17
147
(3042631) Mycobacterium sp identified in Specimen
113
1030
1.10
0.43
2.6
2.7
—
—
—
0
0
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
5
32
1.56
0.42
1.0
1.1
mg/l
0.0
0.0
—
5
26
(3022806) Fractional oxyhemoglobin in Capillary blood
107
974
1.10
0.42
1.8
1.8
%
90.0
89.7
0.21
107
961
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
24
194
1.24
0.41
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
24
194
1.24
0.41
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
24
194
1.24
0.41
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
24
194
1.24
0.41
1.0
1.1
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
13
96
1.35
0.41
1.2
1.2
mmol/l
4.5
6.1
—
5
49
(3041672) Baker's yeast Ab [Presence] in Serum
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
15
0.00
0.41
0.0
3.3
—
—
—
0
0
(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid
0
15
0.00
0.41
0.0
7.8
—
53.0
—
0
6
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
16
0.00
0.41
0.0
1.3
—
2772.9
—
0
16
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
16
0.00
0.41
0.0
8.1
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
16
0.00
0.41
0.0
6.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
20
250
0.80
0.41
1.6
2.0
e6/l
1690.5
16970.7
—
10
136
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
28
231
1.21
0.41
1.5
1.3
%
6.8
27.7
—
5
39
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
37
314
1.18
0.41
1.8
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
37
314
1.18
0.41
1.8
2.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
103
938
1.10
0.40
3.0
3.4
nmol/l
5.4
11.6
0.50
97
914
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
11
79
1.39
0.40
1.1
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
73
653
1.12
0.40
1.1
1.1
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
27
223
1.21
0.39
1.3
1.3
—
—
—
0
0
(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.5
—
44.2
—
0
12
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
301
2861
1.05
0.39
3.1
3.4
u/ml
459.7
2326.8
1.15
252
2416
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
23
187
1.23
0.38
1.1
1.3
nmol/l
169.3
130.7
0.84
16
134
(3051611) Lipemic interference index of Serum or Plasma
90
817
1.10
0.38
2.7
3.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
86
948
0.91
0.38
1.0
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
36
307
1.17
0.38
2.1
2.2
umol/l
56.0
56.0
0.01
25
247
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
129
1192
1.08
0.38
1.4
1.3
nmol/l
0.2
0.3
—
9
75
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
82
905
0.91
0.38
1.6
1.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
118
1087
1.09
0.37
1.4
1.2
u/ml
3.2
3.8
0.22
39
357
(3051101) Glucose [Moles/volume] in Cord blood
10
136
0.73
0.37
6.1
6.9
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
28
234
1.20
0.37
1.2
1.8
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
21
257
0.82
0.37
6.5
3.3
%
44.5
52.3
0.82
21
247
(3011288) Drugs identified in Urine by Screen method
120
1108
1.08
0.36
1.9
3.1
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
25
300
0.83
0.36
25.8
33.2
ug/l
7.2
7.3
0.09
19
272
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
37
318
1.16
0.36
1.2
2.0
%
144.8
155.3
0.45
37
294
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
37
318
1.16
0.36
1.8
2.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
158
1476
1.07
0.36
5.0
5.3
iu/ml
322.6
579.5
0.79
21
203
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
24
198
1.21
0.36
1.0
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
83
912
0.91
0.36
2.8
2.3
mmol/l
105.5
105.4
0.03
83
902
(3041354) Potassium [Moles/volume] in Venous blood
83
912
0.91
0.36
2.8
2.3
mmol/l
4.0
4.0
0.01
83
902
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
43
375
1.15
0.35
1.1
1.1
u/l
1.1
1.1
0.04
17
182
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
6
42
1.43
0.35
1.0
1.0
mmol/l
8.6
8.4
—
6
42
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
58
517
1.12
0.35
1.3
1.2
u/l
33.5
22.4
0.60
51
433
(3038071) Oxygen [Partial pressure] in Mixed venous blood
19
153
1.24
0.35
9.7
7.9
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
188
1771
1.06
0.34
2.4
2.4
ug/min
90.4
94.6
0.07
107
1040
(40768800) Prostate Pathology biopsy report
102
1107
0.92
0.34
1.2
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
61
547
1.12
0.34
1.5
1.6
u/l
5.6
6.0
0.09
29
265
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
11
82
1.34
0.34
1.1
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
62
689
0.90
0.34
1.5
1.5
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
45
1.33
0.33
1.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
12
91
1.32
0.33
2.4
2.8
u/field
0.6
0.7
0.18
12
91
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
156
1663
0.94
0.33
3.4
3.7
u/ml
23.6
38.3
2.73
151
1610
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
28
237
1.18
0.33
2.4
2.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
28
237
1.18
0.33
2.4
2.9
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
10
133
0.75
0.33
1.1
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
54
604
0.89
0.33
2.2
2.1
u/field
2.6
2.1
0.17
28
247
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
6
46
1.30
0.33
1.0
1.0
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
21
253
0.83
0.33
1.3
1.5
mmol/l
7.5
8.3
0.56
15
146
(3033705) Calcium.ionized [Moles/volume] in Venous blood
82
896
0.91
0.32
2.9
2.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
68
750
0.91
0.32
1.7
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
89
817
1.09
0.32
1.4
1.4
nmol/l
0.3
0.3
0.41
70
595
(3016038) Potassium [Moles/volume] in Urine
57
511
1.12
0.32
1.1
1.1
mmol/l
35.3
33.7
0.18
48
431
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
17
137
1.24
0.32
1.5
2.6
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
79
722
1.10
0.32
2.7
3.0
mg/l
48.5
46.9
0.02
57
521
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
14
110
1.27
0.31
2.5
2.0
umol/l
12.1
17.9
1.43
14
110
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
30
348
0.86
0.31
2.7
2.3
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
41
361
1.14
0.31
1.9
2.1
ug/min
74.4
182.2
—
8
85
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
49
437
1.12
0.31
1.3
1.6
ug/l
2.5
5.2
1.34
37
339
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
98
0.71
0.30
1.6
5.3
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
7
100
0.70
0.30
5.3
9.8
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
100
0.70
0.30
3.6
1.9
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
65
715
0.91
0.30
1.6
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
482
4670
1.03
0.29
3.0
3.8
u/ml
45.0
63.0
1.02
459
4491
(3047189) Immunofixation for 24 hour Urine
31
356
0.87
0.29
1.7
1.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
99
1065
0.93
0.29
1.6
1.6
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
8
106
0.75
0.29
1.0
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
106
0.75
0.29
1.0
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
8
106
0.75
0.29
1.0
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
59
535
1.10
0.28
1.3
1.2
u/l
98.1
85.7
0.48
53
464
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
16
195
0.82
0.28
1.6
1.5
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
30
260
1.15
0.28
2.0
2.7
umol/l
25.9
28.6
0.83
21
188
(3044007) Cell count panel - Peritoneal fluid
19
227
0.84
0.28
2.5
2.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
13
103
1.26
0.28
1.7
1.7
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
10
76
1.32
0.28
1.3
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
68
742
0.92
0.28
1.4
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
86
796
1.08
0.27
1.8
1.7
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
8
63
1.27
0.27
1.1
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
68
741
0.92
0.27
1.4
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
21
177
1.19
0.27
1.7
1.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
15
183
0.82
0.27
1.3
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
32
280
1.14
0.27
1.5
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
15
122
1.23
0.27
1.3
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
8
66
1.21
0.26
1.1
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
8
66
1.21
0.26
1.1
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
8
66
1.21
0.26
1.3
2.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
31
272
1.14
0.26
1.1
1.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
488
4743
1.03
0.26
7.8
8.7
%
1.4
1.4
0.17
483
4710
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
68
738
0.92
0.25
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
68
738
0.92
0.25
1.4
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
46
509
0.90
0.25
6.5
6.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
175
1666
1.05
0.25
4.0
4.2
mmol/l
2.3
2.6
0.66
134
1185
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
78
723
1.08
0.25
3.1
2.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
55
602
0.91
0.25
1.7
1.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
9
75
1.20
0.25
1.1
1.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
33
292
1.13
0.25
1.0
1.0
u/ml
0.4
2.0
—
6
44
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
82
0.73
0.24
1.2
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
71
766
0.93
0.24
1.2
1.1
%
94.0
96.0
0.26
66
719
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
32
360
0.89
0.24
4.7
3.4
—
—
—
0
0
(4211845)
44
398
1.11
0.23
3.4
3.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
174
1661
1.05
0.23
1.6
2.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
143
1359
1.05
0.23
1.4
1.4
—
—
—
0
0
(44806420)
25
218
1.15
0.23
2.6
2.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
38
342
1.11
0.22
7.1
10.9
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
17
200
0.85
0.22
1.2
1.2
pmol/l
195.0
310.0
—
10
144
(3015183) Erythrocyte sedimentation rate
34
304
1.12
0.22
2.1
1.2
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
5
40
1.25
0.22
8.2
8.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
71
660
1.08
0.22
1.5
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
71
660
1.08
0.22
1.5
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
71
660
1.08
0.22
1.5
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
19
221
0.86
0.22
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
30
337
0.89
0.22
1.3
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
18
153
1.18
0.22
1.2
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
54
587
0.92
0.22
1.1
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
79
1.27
0.22
1.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
10
79
1.27
0.22
2.2
2.0
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
5
41
1.22
0.22
1.0
1.0
u/field
1.0
1.0
—
5
26
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
41
1.22
0.22
1.2
1.5
umol/24h
227.2
338.1
—
5
41
(3018291) Platelet Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
1.2
—
0
10
(3002719) Hemoglobin [Mass/volume] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
174
1667
1.04
0.21
1.6
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021367) Citalopram [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
123.0
—
0
5
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
20
173
1.16
0.20
1.1
1.1
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.4
—
1.9
—
0
14
(3027456) Digoxin [Moles/volume] in Serum or Plasma
152
1455
1.05
0.20
3.2
3.1
nmol/l
0.8
0.8
1.43
110
1115
(3048929) Epstein Barr virus Ab [Presence] in Serum
175
1821
0.96
0.19
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
82
772
1.06
0.19
1.1
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
51
1.18
0.19
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
6
51
1.18
0.19
1.3
1.0
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
58
539
1.08
0.19
1.0
1.0
ng/l
332.3
341.4
0.08
41
383
(3051651) Icteric interference index of Serum or Plasma
49
452
1.08
0.19
2.8
3.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
114
1085
1.05
0.19
1.8
1.4
mu/l
51.7
57.0
0.23
102
965
(21494567) Legionella sp IgM Ab [Presence] in Serum
6
52
1.15
0.19
1.3
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
21
184
1.14
0.19
1.0
1.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
13
154
0.84
0.19
1.6
3.5
ng/l
105.4
138.5
—
5
53
(3028300) Cannabinoids [Presence] in Urine
174
1674
1.04
0.18
1.6
2.1
—
—
—
0
0
(4268621)
79
744
1.06
0.18
2.6
2.3
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
7
58
1.21
0.18
1.0
1.1
—
9.8
—
0
12
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
58
541
1.07
0.18
1.0
1.0
ng/l
821.1
717.3
0.87
42
373
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
23
204
1.13
0.18
1.2
3.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
309
3008
1.03
0.17
2.0
1.9
ug/l
2.2
2.3
0.07
261
2673
(44790047)
87
825
1.06
0.17
1.7
1.5
—
—
—
0
0
(44790049)
87
825
1.06
0.17
1.7
1.5
—
—
—
0
0
(44806118)
87
825
1.06
0.17
1.7
1.5
—
—
—
0
0
(44790048)
87
825
1.06
0.17
1.7
1.5
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
32
351
0.91
0.17
1.1
1.1
u/ml
4.3
6.0
—
6
57
(40758047) Lysozyme [Mass/volume] in Pleural fluid
5
66
0.76
0.17
1.8
1.2
mg/l
11.4
8.4
—
5
59
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
13
152
0.86
0.16
1.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
13
152
0.86
0.16
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
82
777
1.06
0.16
1.3
1.3
—
—
—
0
0
(4306422)
110
1051
1.05
0.16
1.2
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
26
234
1.11
0.16
1.7
1.7
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
8
68
1.18
0.16
1.3
1.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
437
4462
0.98
0.16
6.4
6.9
mmol/l
24.9
24.9
0.00
432
4431
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
43
398
1.08
0.16
1.3
1.4
pmol/l
48.8
138.0
0.63
20
126
(3024891) Influenza virus A+B Ag [Presence] in Specimen
182
1760
1.03
0.16
1.2
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
58
544
1.07
0.16
1.0
1.0
ng/l
40.2
44.0
0.33
41
379
(4212803)
8
72
1.11
0.16
1.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
13
111
1.17
0.15
1.2
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
8
73
1.10
0.15
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
54
506
1.07
0.15
1.4
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
19
168
1.13
0.15
1.1
1.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
35
380
0.92
0.15
3.3
3.4
mu/l
30.1
26.6
0.21
35
364
(3027035) Albumin [Mass/time] in 24 hour Urine
9
80
1.13
0.15
1.3
1.3
—
577.7
—
0
10
(40768793) Breast Pathology biopsy report
212
2061
1.03
0.14
1.3
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
40
372
1.08
0.14
3.6
3.6
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
55
583
0.94
0.14
2.2
2.3
ml
711.3
638.6
0.35
36
392
(3014891) Appearance of Pleural fluid
8
96
0.83
0.13
1.6
1.5
—
—
—
0
0
(4198724)
19
211
0.90
0.13
3.6
2.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
44
413
1.07
0.13
1.3
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
25
229
1.09
0.12
1.1
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
79
824
0.96
0.12
1.1
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
39
415
0.94
0.11
1.5
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
191
1864
1.03
0.11
3.0
3.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
211
2062
1.02
0.11
2.5
2.5
g/l
3.7
3.6
0.20
197
1960
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
16
178
0.90
0.11
1.3
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
14
124
1.13
0.11
1.4
1.5
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
105
1016
1.03
0.10
1.3
1.3
pmol/l
306.6
303.3
0.03
88
776
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
125
1214
1.03
0.10
1.4
1.4
u/ml
109.5
118.8
0.59
33
256
(3026470) Cobalt [Mass/volume] in Blood
54
515
1.05
0.10
2.1
2.0
ug/l
2.4
3.6
0.88
45
450
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
849
8571
0.99
0.10
3.3
4.0
ug/l
25.3
21.9
0.09
663
6944
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
20
183
1.09
0.10
1.0
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
337
3424
0.98
0.10
3.0
4.1
mmol/l
24.1
24.3
0.99
299
3081
(3033799) Differential panel - Peritoneal fluid
26
242
1.07
0.09
1.9
2.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
141
1375
1.03
0.09
2.2
2.1
u/l
6166.3
3939.0
0.28
47
565
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
174
1.09
0.09
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
27
252
1.07
0.09
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
21
227
0.92
0.09
1.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1929
19389
0.99
0.09
1.4
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
12
134
0.90
0.08
1.7
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
62
597
1.04
0.08
1.7
2.1
%
11.8
11.0
0.94
62
597
(40757373) Influenza virus identified in Isolate
13
144
0.90
0.08
1.1
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
607
6127
0.99
0.08
7.3
8.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
7
66
1.06
0.08
3.3
2.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
57
549
1.04
0.07
3.6
2.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
11
98
1.12
0.07
1.5
1.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
72
0.83
0.07
1.8
1.8
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
8
74
1.08
0.07
2.5
2.1
—
—
—
0
0
(3010421) pH of Blood
198
1947
1.02
0.07
3.9
4.1
ph
7.4
7.4
0.12
171
1637
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
146
1431
1.02
0.07
1.5
1.8
nmol/l
0.9
0.8
0.54
109
1193
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
340
3359
1.01
0.07
2.3
2.8
%
0.7
0.7
0.23
325
3224
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
12
108
1.11
0.07
1.7
1.4
%
3.0
9.3
—
7
60
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
254
2504
1.01
0.07
2.7
3.1
u/ml
0.3
0.4
0.08
137
1438
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
81
0.86
0.07
1.1
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
95
926
1.03
0.07
2.5
2.2
pg
32.9
32.7
0.20
95
920
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
7
83
0.84
0.07
1.1
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
9
86
1.05
0.07
1.0
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
99
1014
0.98
0.07
1.2
1.1
%
121.4
118.7
0.47
88
912
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
61
630
0.97
0.06
1.9
1.8
mg/l
3.5
4.1
0.33
55
597
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
8
95
0.84
0.06
1.1
1.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
52
502
1.04
0.06
2.2
2.1
ug/l
1.9
2.5
0.97
38
425
(40765089) Chromosome analysis panel - Blood by G-banded
9
101
0.89
0.06
1.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
9
102
0.88
0.06
1.0
1.2
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
9
105
0.86
0.06
1.1
1.9
mmol/l
1.4
2.7
—
9
92
(1761868) Lipid panel - Serum or Plasma
2541
25488
1.00
0.06
3.1
2.9
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
647
6516
0.99
0.06
6.3
6.8
mmol/l
1.4
1.3
0.52
626
6298
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
90
1.11
0.05
1.0
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
10
90
1.11
0.05
3.3
2.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
128
1302
0.98
0.05
1.5
2.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
54
524
1.03
0.05
1.1
1.2
mg/l
41.9
40.9
0.06
47
439
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
11
100
1.10
0.05
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
335
3381
0.99
0.05
1.8
1.7
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
16
171
0.94
0.05
3.1
2.4
mmol/l
8.4
7.5
—
10
102
(3003129) Base excess in Capillary blood by calculation
18
191
0.94
0.04
1.9
1.8
mmol/l
-0.1
0.9
0.64
18
181
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
88
863
1.02
0.04
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
21
199
1.06
0.04
1.0
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
27
282
0.96
0.04
2.3
2.2
e6/l
392.2
5227.6
0.87
17
196
(3044242) Glucose [Moles/volume] in Arterial blood
39
377
1.03
0.04
1.4
2.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
108
1062
1.02
0.04
1.2
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
23
219
1.05
0.04
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
39
379
1.03
0.03
1.5
1.3
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
28
270
1.04
0.03
1.4
2.0
u/ml
8723.6
48115.0
—
5
38
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
220
2182
1.01
0.03
2.3
2.1
%
90.8
92.0
0.33
206
2039
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
18
189
0.95
0.03
1.3
1.2
ug/l
40.8
325.7
—
6
105
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
91
897
1.01
0.03
1.9
2.0
ug/l
14.4
23.3
5.19
84
883
(3020191) Ethanol [Moles/volume] in Serum or Plasma
54
529
1.02
0.03
1.3
1.5
promille
1.3
1.2
0.05
45
405
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
40
390
1.03
0.02
1.2
1.2
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
24
249
0.96
0.02
1.5
1.4
%
52.1
63.4
0.59
18
211
(3016750) Collection duration of Urine
41
420
0.98
0.02
1.8
2.2
min
482.6
496.7
0.42
28
312
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
199
2005
0.99
0.02
2.7
2.4
%
193.3
196.3
0.19
185
1907
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
47
480
0.98
0.02
1.1
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
48
490
0.98
0.02
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
108
1068
1.01
0.02
1.4
1.2
u/ml
3.3
4.4
0.47
52
463
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
52
510
1.02
0.02
1.0
1.1
mg/l
299.8
270.7
0.29
46
443
(1616796) Gas panel - Central venous blood
162
1607
1.01
0.02
3.8
3.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
581
5829
1.00
0.02
1.4
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
14
147
0.95
0.01
1.6
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
88
889
0.99
0.01
1.3
1.3
—
34.2
—
0
6
(3016879) Cocaine [Presence] in Urine
155
1540
1.01
0.01
1.6
2.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
18
187
0.96
0.01
1.4
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
56
552
1.01
0.01
1.2
1.3
mmol/l
11.6
12.0
0.10
11
152
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
213
1.03
0.01
1.3
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
63
638
0.99
0.01
1.4
1.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
72
712
1.01
0.01
4.4
4.9
u/ml
227.4
93.1
0.42
19
199
(3034426) Prothrombin time (PT)
25
257
0.97
0.01
1.4
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
75
742
1.01
0.01
1.9
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
164
1631
1.01
0.01
1.6
2.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
33
323
1.02
0.01
1.4
2.0
umol/l
43.1
130.6
4.44
14
169
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
14
146
0.96
0.00
1.0
1.1
—
5.2
—
0
19
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
22
214
1.03
0.00
1.1
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
107
1064
1.01
0.00
1.1
1.1
iu/ml
50.9
10015.0
0.55
22
239
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
119
1196
0.99
0.00
1.2
1.3
u/l
24.1
37.0
2.00
99
1046
(40758292) HTLV I+II Ab panel - Serum
11
113
0.97
0.00
1.6
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
17
167
1.02
0.00
1.1
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
22
223
0.99
0.00
1.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
36
357
1.01
0.00
3.8
3.9
—
—
—
0
0
(4027681)
39
393
0.99
0.00
1.2
1.2
—
—
—
0
0
(4133840)
17
166
1.02
0.00
1.1
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
47
467
1.01
0.00
1.1
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
28
276
1.01
0.00
1.6
1.4
—
1782790.4
—
0
14
(3008536) Aspergillus sp Ab [Presence] in Serum
14
145
0.97
0.00
2.0
2.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
18
175
1.03
0.00
1.2
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
22
225
0.98
0.00
2.2
1.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
22
225
0.98
0.00
1.1
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
62
615
1.01
0.00
1.4
1.4
—
—
—
0
0
(3036489) Thrombin time
269
2695
1.00
0.00
2.1
2.0
s
21.2
21.6
0.52
230
2364
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
12
118
1.02
0.00
1.3
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
170
1701
1.00
0.00
2.9
3.4
u/ml
538.0
601.1
0.05
154
1544
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
39
391
1.00
0.00
1.8
1.9
u/field
2.8
2.6
0.08
29
276
(3047352) Trisomy 18 risk [Likelihood] in Fetus
62
619
1.00
0.00
1.4
1.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
10
99
1.01
0.00
1.6
1.3
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
11
109
1.01
0.00
2.9
3.0
—
26.0
—
0
14
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
15
151
0.99
0.00
7.9
5.0
u/l
35.5
65.8
—
6
51
(3029612) Listeria sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
8
0.00
0.00
0.0
2.3
—
10.6
—
0
8
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
7
71
0.99
0.00
1.1
1.1
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
5
57
0.88
0.00
1.0
1.0
—
—
—
0
0
(3008343) Lysozyme [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
0.5
—
0
6
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
56
0.89
0.00
2.4
4.6
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
7
0.00
0.00
0.0
5.6
—
—
—
0
0
(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
6
66
0.91
0.00
2.7
2.3
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
5
52
0.96
0.00
1.2
1.3
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
9
89
1.01
0.00
2.2
3.3
umol/l
28.8
40.0
—
9
74
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
7
75
0.93
0.00
1.1
1.1
—
—
—
0
0
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
7
75
0.93
0.00
1.1
1.1
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025504) Homovanillate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
58
0.86
0.00
1.2
1.0
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
7
77
0.91
0.00
1.1
1.4
mmol/l
189.3
164.9
—
7
67
(3010015) Selenium [Moles/volume] in Serum or Plasma
5
49
1.02
0.00
1.6
2.1
umol/l
1.5
1.4
—
5
43
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
7
77
0.91
0.00
1.3
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
7
76
0.92
0.00
1.0
1.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
66
0.91
0.00
1.0
1.0
—
—
—
0
0
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
17.6
—
0
7
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
7
74
0.95
0.00
1.9
1.5
umol/l
60.9
44.1
—
7
74
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
5.8
—
14.0
—
0
5
(3040794) Aluminum [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint K11_LICHEN_PLANUS_WIDE and mortality.

Females

Parameter HR [95% CI] p-value
K11_LICHEN_PLANUS_WIDE 0.843 [0.76, 0.93] < 0.001
Birth year 0.994 [0.99, 1.0] 0.143

During the follow-up period (1.1.1998 — 31.12.2019), 2485 out of 24901 females with K11_LICHEN_PLANUS_WIDE died.

Males

Parameter HR [95% CI] p-value
K11_LICHEN_PLANUS_WIDE 0.832 [0.74, 0.93] 0.001
Birth year 0.988 [0.98, 1.0] 0.012

During the follow-up period (1.1.1998 — 31.12.2019), 1561 out of 13401 males with K11_LICHEN_PLANUS_WIDE died.

Mortality risk

Mortality risk for people of age

years, who have K11_LICHEN_PLANUS_WIDE.

N-year risk Females Males
1 0.077% 0.16%
5 0.43% 1.002%
10 1.069% 2.575%
15 2.15% 4.734%
20 4.047% 8.05%

Relationships between endpoints

Index endpoint: K11_LICHEN_PLANUS_WIDE – Lichen ruber planus, wide definition including periferal and oral lichen planus

GWS hits: 15

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data